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PREFACE
GENERAL INTRODUCTION
It is widely accepted that the nucleus tractus solitarii (NTS) is a major integrative
center for processing sensory information involved in cardiovascular control and other
autonomic reflexes.

The NTS, through its reciprocal connections with medullary,

pontine and hypothalamic centers, modulates reflex reactivity creating specific patterns
of autonomic responses observed in physiological and pathological situations, for
example, stress, the defense response, exercise, hemorrhage etc.
Tonic blood pressure regulation involves input from baroreceptor afferents to the
NTS.

Baroreceptors

are stretch receptors,
located in the arterial
walls

mainly

aortic

arc

in

the

and

the
GLU

bifurcation
carotid

of

arteries

These

GLU

the
(20)

.

GLU

GLU

SG

receptors

increase their activity in
response to increases
of

arterial

which

pressure

distends

arterial walls.

the

Figure 1. Medullary pathways of the baroreceptor reflex. Abbreviations: GABA,
J-amino-butyric acid; GLU, glutamate; NTS, nucleus of the solitary tract; CVLM,
caudal ventrolateral medulla; iRVLM, rostral ventrolateral medulla; AMB,
nucleus ambiguus; IML, intermediolateral column of spinal cord; SG,
sympathetic ganglion; IX,. glossopharyngeal nerve; X, vagal nerve. Modified
from Dampney RAL 1994 (20).

Baroreceptor afferents reach the NTS via the vagus and

glossopharyngeal nerves and activate central neurons of this baroreflex pathway via
glutamatergic mechanism (Figure 1). The same nerves also provide afferents from
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arterial chemoreceptors and cardiopulmonary baro- and chemoreceptors to the NTS.
Efferent control of the cardiovascular system is provided via two main factors:
the resistance of the peripheral vasculature and cardiac output, which depends on
cardiac contractility and heart rate (HR). According to Ohm's law applied to circulating
fluids P=RxCO, where P is arterial pressure, R is total peripheral resistance and CO is
cardiac output. Cardiac contractility and HR are increased by activation of efferent
sympathetic nerves releasing norepinephrine, which acts via cardiac E1- adrenergic
receptors. HR is decreased by efferent vagal fibers releasing acetylcholine operating via
cardiac muscarinic receptors(20). Medium and small arteries increase and decrease
peripheral resistance via vasoconstriction and vasodilation, respectively.

Vascular

control is mediated via efferent sympathetic vasoconstrictor nerves which are tonically
active at resting conditions. The major vasoconstrictor mediator released from efferent
sympathetic terminals is norepinephrine acting via D1-adrenergic receptors located in
vascular smooth muscles(20).

Sympathetic vasoconstrictor tone is generated in the

rostral ventrolateral medulla (RVLM) (Figure 1). RVLM neurons activate sympathetic
preganglionic neurons located in the intermediolateral column (IML) of the spinal cord
via a glutamatergic mechanism. Efferent axons of the preganglionic neurons terminate
in the sympathetic ganglia and activate ganglionic neurons via the release of
acetylcholine operating via nicotinic receptors.

The ganglionic neurons send their

efferent, postganglionic fibers to the peripheral vasculature and cause vasoconstriction
via D1-adrenergic receptors. At rest the efferent sympathetic nerves generate tonic
vasoconstriction. Increases and decreases in this efferent sympathetic tone result in
vasoconstriction and vasodilation, respectively.
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Tonic afferent traffic from arterial baroreceptors and tonic efferent sympathetic
tone mediate constant regulation of arterial pressure via corrections of efferent
sympathetic (and cardiac vagal) activity mediated by medullary cardiovascular centers
illustrated in Figure 1.

For example, increases in arterial blood pressure increase

afferent baroreceptor traffic, which activate primary central neurons and interneurons
located in the NTS via a glutamatergic mechanism. NTS neurons activate inhibitory
GABA-ergic neurons located in the caudal ventrolateral medulla (CVLM) also via a
glutamatergic mechanism.

Activated CVLM neurons inhibit RVLM neurons via the

release of GABA from their axons terminating in the RVLM; this decreases efferent
sympathetic tone which allows peripheral arteries to dilate, decrease peripheral
resistance and decrease arterial pressure toward normal values. In contrast, decreases
in arterial pressure, cause unloading (relaxation) of arterial baroreceptors which
decreases afferent activation of NTS neurons, decreases activation of CVLM and
reduces tonic baroreceptor inhibition of sympathetic vasoconstrictor tone generated in
the RVLM.

This allows for the increase of efferent sympathetic vasoconstriction,

increase in peripheral resistance and increase of arterial pressure back toward normal
values.
Although most of the efferent sympathetic fibers supplying the peripheral
vasculature mediate vasoconstriction (releasing norepinephrine and to a lesser extent
ATP and NPY) some sympathetic efferents may produce active vasodilation in a
regionally specific manner(10; 13; 20; 21; 43; 57). For example, the iliac vasculature may be
actively dilated via the release of NO from efferent sympathetic nerves(21;

57)

or by

epinephrine which was previously absorbed from the circulation by sympathetic
terminals(10). Sympathetic vasodilation may be provided also by calcitonin gene related
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peptide (CGRP) or adenosine which is generated by ectonucleotidases from neuronally
released ATP(13;

43; 94)

. These vasodilatory mechanisms, which oppose the prevailing

efferent sympathetic vasoconstriction contribute to the fine tuning of regional
vasculature and to specific patterns of autonomic responses, which require the
redistribution of blood between vascular beds.
An important sympathetic output which provides humoral control of regional
vascular beds is the adrenal medulla.

Chromaffin cells of the adrenal medulla are

modified sympathetic ganglionic neurons and as such they are activated by
preganglionic nerves that release acetylcholine operating via nicotinic receptors(20).
Although the activated adrenal medulla releases epinephrine and norepinephrine (in
ratio of ~4:1), the main adrenergic effect is provided by circulating epinephrine(31). The
majority of circulating norepinephrine is generated by sympathetic nerve terminals,
therefore, the relatively small amount of norepinephrine released from the adrenal
medulla is negligible. Epinephrine causes peripheral vasodilation via activation of E2adrenergic receptors. Differential regional effects of circulating epinephrine depend on
differential distribution of E2-adrenergic receptors in different vascular beds(90). These
receptors are preferentially expressed in the muscle vascular bed which contributes to
active vasodilation of the muscle vasculature, for example during stress or the
hypothalamic defense response(93).
The other important humoral vasoactive factor controlled by the baroreflex
mechanisms is vasopressin which is a potent vasoconstrictor operating via peripheral
V1 receptors(17).

Vasopressin is synthesized in the magnocellular portion of

hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei(17;

20)

. From these

hypothalamic nuclei vasopressin is delivered via descending axons to the posterior part
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of the pituitary gland and released into the circulation. Under normal, resting conditions
vasopressin is tonically inhibited/restrained by the baroreflex mechanism shown in
Figure 2.

Therefore

normal, resting levels of
vasopressin remain low,

NE

usually between 1 - 4
pg/ml(17;

32; 53; 54)

.

The

tonic baroreflex inhibition
of vasopressin release is
provided mainly via a
multisynaptic,
glutamatergic

pathway

Figure 2. Baroreflex control of vasopressin release. GABA, J-aminobutyric acid; NE, norepinephrine; NTS, nucleus of the solitary tract;
CVLM, caudal ventral lateral medulla; RVLM, rostral ventral lateral
medulla; IML, intermediolateral cell column; LC, locus ceruleus; DBB,
diagonal band of Broca; PVN, paraventricular nucleus; SON supraoptic
nucleus; IX, glossopharyngeal nerve; vagal nerve.
Modified from
Dampney RAL 1994 (20).

which begins in the NTS
neurons and then travels via the locus ceruleus and diagonal band of Broca reaching
GABA-ergic neurons located in the periphery of the hypothalamic paraventricular
nucleus (Figure 2)(20). It was also postulated that inhibition of vasopressin release may
involve inhibition of noradrenergic CVLM neurons by NTS GABA-ergic interneurons
activated by afferent baroreflex traffic. These CVLM neurons are believed to tonically
facilitate vasopressin release under normal conditions(20). Decreases in arterial blood
pressure unload baroreceptors and decrease baroreceptor inhibition of vasopressin
release. This results in disinhibition of magnocellular PVN and SON neurons which
release vasopressin into the posterior pituitary gland and from there into the circulation.
The activity of basic medullary cardiovascular centers is modulated by
descending (mostly hypothalamic) and ascending (spinal) projections(58; 65). Descending
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fibers, mostly from hypothalamic paraventricular and dorsomedial nuclei, or ascending
spinal afferents may inhibit baroreflex activity at the level of the NTS. Descending
hypothalamic projections to RVLM and IML may also directly modulate regional
sympathetic drive. Baroreflex mechanisms together with the descending and ascending
(afferent) projections create specific patterns of autonomic responses. For example,
during stimulation of the hypothalamic defense area (which mimics a stress response)
the descending hypothalamic projections activate intrinsic NTS GABA-ergic neurons
which inhibit glutamatergic transmission in the baroreflex arc(40;

49)

.

Similar

modulation/resetting of baroreflex mechanisms occurs during exercise via both
descending (central command) and ascending projections from muscle receptors(58; 62;
63)

. This allows for a simultaneous increase of arterial pressure and heart rate and

contractility which is a key cardiovascular adjustment which increases cardiac output
and skeletal muscle perfusion in these situations.

The other crucial adjustment

increasing muscle blood flow during stress is the redistribution of blood from the visceral
to the muscle vascular bed.

This is achieved via simultaneous vasoconstriction of

visceral vascular beds and active muscle vasodilation, usually measured as hindlimb
vasodilation.

The active hindlimb vasodilation is mediated mostly via E2-adrenergic

receptors preferentially located in the muscle vascular beds(90), which are activated by
epinephrine released from the adrenal medulla. This mechanism is crucial for stress
related hindlimb vasodilation in rats(2; 93) whereas in dogs, cats and humans sympathetic
cholinergic vasodilation may also contribute to this response(39; 46; 60). Epinephrine may
be also released into the hindlimb vasculature from sympathetic terminals which
previously absorbed circulating epinephrine(10;

22)

.

It has been also reported that

sympathetic nerves supplying the hindlimb vasculature may release nitric oxide(21;

57)

.
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Similar mechanisms as those described above may create other differential patterns of
regional cardiovascular responses; for example, during hemorrhage, thermoregulatory
adjustments and other physiological and pathological situations(50; 78; 91).
Adenosine as a neuromodulator in central cardiovascular control
Numerous studies from our laboratory and by others showed that purinergic
mechanisms (operated by adenosine and its nucleotides) are involved in cardiovascular
control at the level of the NTS(4; 5; 7; 8; 15; 37; 51; 52; 55; 72; 77; 82; 85). Adenosine operating in the
NTS originates from the breakdown of ATP, both intra- and extracellularly, and is
involved under both physiological and pathological conditions.

Under physiological

conditions neuronally released ATP is broken to adenosine via ectonucleotidases(94).
This may occur during stress or the hypothalamic defense response(82). ATP may be
also neuronally released as a co-transmitter with glutamate in the baroreflex arc at the
level of the NTS, as suggested by previous studies from our laboratory(70;

74)

. Under

pathological conditions, such as severe hemorrhage, ischemia, and hypoxia,
intracellular ATP is catabolized to adenosine in hypoxic cells and adenosine is directly
released into the extracellular space without the contribution of nucleoside transporters
(56; 84; 89; 92)

. Therefore, adenosine is a neuromodulator activated in life threatening

situations to regain homeostasis.

A recent paper from our laboratory showed that

adenosine operating via both A1 and A2a receptors located in the NTS contribute to the
paradoxical renal sympathoinhibition and cardiac slowing observed in the hypotensive
stage of severe hemorrhage(78). In addition, the same study showed that both A1 and
A2a adenosine receptor subtypes may exert tonic effects on hemodynamic and
sympathetic variables under control conditions. Thus adenosine operating in the NTS
may play an important role as a neuromodulator of reflex control of the circulation under
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normal, physiological conditions. In a recent study from our laboratory we found that A1
adenosine receptor stimulation in the NTS resets baroreflex functions towards higher
mean arterial pressure (MAP)(71).
A1 adenosine receptor activation in the central nervous system, including the
NTS, stimulates an inhibitory G protein resulting in decreased cAMP formation, lower
intracellular Ca2+ levels and thus decreased neurotransmitter release from synaptic
terminals(59).

A2a receptor activation operates in a reciprocal fashion, activating a

stimulatory G protein, increasing cAMP and Ca2+ influx and consequently facilitating
neurotransmission(59). Postsynaptic A1 and A2a adenosine receptors may also inhibit
and activate neurons, respectively(59). Therefore selective activation of adenosine A1
and A2a receptor subtypes in the NTS often, although not always, evokes reciprocal
hemodynamic and sympathetic responses.
Selective activation of NTS A1 adenosine receptors typically evokes pressor and
sympathoexcitory responses consistent with the inhibition of glutamatergic transmission
at the baroreflex arc(4;

8; 76)

. For example, Scislo and O’Leary showed that sino-aortic

denervation plus vagotomy as well as blockade of glutamatergic transmission in the
NTS eliminated the pressor and sympathoactivatory responses(76). A recent study from
our laboratory directly confirmed that activation of NTS A1 adenosine receptors resets
regional sympathetic and heart rate baroreflex functions toward higher MAP which is
consistent with presynaptic inhibition of glutamate release from baroreceptor
terminals(71).
In contrast, selective activation of NTS A2a adenosine receptors, as well as
nonselective activation of these receptors with adenosine evokes baroreflex-like
responses, i.e. decreases in MAP and HR. Numerous data suggested that presynaptic
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A2a adenosine receptors may facilitate release of glutamate from baroreceptor afferents
terminating in the NTS(4; 7; 8; 15; 51; 52; 85; 88). However, analysis of regional sympathetic
responses to selective stimulation of NTS A2a adenosine receptors leads to the opposite
conclusions. Although the stimulation inhibited renal sympathetic nerve activity (RSNA),
which is consistent with activation of baroreflex pathway, lumbar sympathetic nerve
activity (LSNA) did not change significantly, whereas preganglionic adrenal sympathetic
nerve activity (pre-ASNA) increased, which is inconsistent with the effects evoked by
activation of the baroreflex pathway(73;

74)

.

It should be stressed that all these

sympathetic outputs were uniformly inhibited when arterial baroreceptors were
stimulated with increases in MAP(68). In addition, bilateral sinoaortic denervation plus
vagotomy, essentially the denervation of baroreceptor input to the NTS, did not affect
the depressor and renal sympathoinhibitory responses mediated via NTS A2a adenosine
receptors(74). Also, blockade of glutamatergic transmission in the NTS did not abolish
the baroreflex-like response to stimulation of NTS A2a adenosine receptors(75). Finally, a
recent study from our laboratory directly confirmed that selective stimulation of NTS A2a
adenosine receptors did not reset baroreflex functions towards lower MAP, which would
be expected if A2a adenosine receptors facilitated baroreflex transmission(37). This study
strongly suggested that hemodynamic and regional sympathetic responses to
stimulation of NTS A2a adenosine receptors are mediated via non-baroreflex
mechanisms.
Typically,

NTS

A1

and

A2a

adenosine

receptors

exert

counteracting

hemodynamic effects: increases and decreases in MAP and RSNA as well as
vasoconstriction and vasodilation, respectively(4;

8; 47; 73; 74; 76)

. Interestingly, despite of

those reciprocal effects both receptor subtypes preferentially increase sympathetic
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nerve activity directed to the adrenal medulla(74-76).

This suggests that adenosine

operating in the NTS via both receptor subtypes may preferentially activate the adrenal
medulla, release epinephrine into the circulation and exert vasodilation in the muscle
vascular bed via activation of E-adrenergic receptors. Yardley and Hilton suggested
that in the rat epinephrine release is a major vasodilator of the hindlimb vasculature in
response to stress or stimulation of the hypothalamic defense area(93). These data
taken together suggest that both A1 and A2a adenosine receptors may be involved in
mechanisms mediating stress and the defense response.
Adenosine and autonomic response to stress
The hypothalamic defense response (HDR) is an experimental model which
allows one to study stress induced patterns of autonomic responses in anesthetized
animals. These patterns may be evoked by precisely controlled electrical or chemical
stimulation of forebrain, diencephalic and midbrain stress related structures: central
amygdala,

posterior/dorsomedial

hypothalamus

and

periaqueductal

grey,

respectively(14; 20; 24; 26; 79; 93). The hypothalamic defense response consists of increases
in MAP, HR, efferent sympathetic nerve activity, pulmonary ventilation and is
accompanied with powerful vasodilation in the muscle vascular bed, especially in the
hindlimb vasculature(93). These responses are at least partially mediated via inhibition
of baroreflex mechanisms at the level of the NTS(40; 49). Several studies from Spyer's
laboratory showed that adenosine contributes to the pressor component of HDR. For
example, blockade of A1 adenosine receptors via microinjections of the selective
antagonist, 8-Cyclopentyl-1,3-dipropylxanthine, into the IV ventricle, in close proximity to
the NTS, attenuated the pressor component of HDR(80).

The blockade of

ectonucleotidases, which prevents the conversion of neuronally released ATP to
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adenosine in the NTS, also attenuated the pressor component of HDR(82). This study
strongly suggested that during HDR, ATP is neuronally released into the NTS and
becomes a source of adenosine which subsequently facilitates the pressor response.
Finally, the most recent paper from this group directly confirmed that adenosine levels in
the NTS increase during HDR(19). However, the contribution of NTS adenosine receptor
subtypes to hindlimb vasodilation has not been studied in respect to HDR. Taking into
consideration that the activation of both A1 and A2a adenosine receptors located in the
NTS preferentially increases sympathetic efferent activation of the adrenal medulla(73; 74;
76)

, and that E-adrenergic mechanism is the crucial mechanism of hindlimb vasodilation

in rats(93) it is likely that adenosine operating in the NTS may significantly contribute to
the stress-related redistribution of blood from the viscera to the skeletal muscle.
Previous studies from our laboratory indicated that activation of NTS A2a
adenosine receptors elicits preferential vasodilation in the iliac vascular bed directed
mostly to the hindlimb in the rat(7). The subsequent study showed that the hindlimb
vasodilation was mediated by both neural and humoral mechanisms(42).

After ȕ-

adrenergic blockade, NTS A2a receptor mediated responses turned from depressor to
pressor and from hindlimb vasodilation to hindlimb vasoconstriction.

Lumbar

sympathectomy as well as bilateral adrenalectomy attenuated the hindlimb vasodilation.
Combined lumbar sympathectomy and bilateral adrenalectomy abolished the response.
In addition, a recent study from our laboratory showed that activation of NTS A1
adenosine receptors inhibits baroreflex mechanisms(71), similarly as it occurs during
HDR(49). Taken together the results of Spyer’s group and those from our laboratory,
these data suggest that adenosine acting via A1 receptors in the NTS may contribute to
the pressor component of HDR, whereas adenosine A2a (and to some extent A1)
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receptors located in the NTS may contribute to HDR related hindlimb vasodilation via a
E2-adrenergic mechanism(7; 19; 42; 49; 71; 80; 82). However, these hypotheses have yet to be
directly proven.
NTS A1 adenosine receptors and counteracting vascular effects
Previous studies from our laboratory suggested that adenosine A1 receptors may
also contribute to HDR related hindlimb vasodilation, as selective stimulation of these
receptors preferentially activates sympathetic output directed to the adrenal medulla(76).
This may result in the release of epinephrine and E-adrenergic vasodilation in the
hindlimb vasculature similar to that observed following selective stimulation of NTS A2a
adenosine receptors(42).

However, the cardiovascular actions of NTS A1 adenosine
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Figure 3. Mean arterial pressure (MAP), Iliac blood flow (IBF), and iliac vascular
conductance (IVC) responses to microinjection of CPA (330 pmol/50nL), an A1
adenosine receptor agonist, into the subpostremal NTS. Intact (INT), ȕ-adrenergic
blockade (ȕX), bilateral adrenalectomy (ADX), lumbar sympathectomy (LX), and
combined adrenalectomy plus lumbar sympathectomy (ADX + LX). Microinjections of
CPA denoted by vertical arrow. Reprinted from McClure et al. 2005 (47).

receptors seem to be more complex than that elicited by NTS A2a adenosine receptor
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subtypes. NTS A1 adenosine receptors, in addition to the aforementioned potential Eadrenergic vasodilation, exert mostly pressor and vasoconstrictor effects; selective
activation

of

these

receptors

elicits

uniform,

although

differential,

regional

sympathoactivation. These counteracting mechanisms are most likely responsible for
the relatively high variability of MAP responses triggered by selective activation of NTS
A1 adenosine receptors: pressor, but also biphasic and depressor responses were
observed(76).

The competition between neural vasoconstriction and epinephrine

mediated vasodilation may be especially powerful in the hindlimb vascular bed where
expression of E-adrenergic receptors is relatively greater than in other vascular beds
(90)

. In the recent study from our laboratory I confirmed this hypothesis showing that

selective stimulation of NTS A1 adenosine receptors evokes simultaneous ȕ2-adrenergic
vasodilation and sympathetic/humoral vasoconstriction in the iliac vascular bed with
prevailing pressor and vasoconstrictor responses(47). The variability of the responses
(pressor vs. depressor and iliac vasoconstriction vs. vasodilation) were relatively high in
intact animals: ~70% pressor and ~65% iliac vasoconstrictor responses were observed.
These results were similar to those previously observed in our laboratory(76). The initial
variability of the responses observed in intact animals (INT) was completely eliminated
following ȕ-adrenergic blockade (ȕX) as well as following bilateral adrenalectomy
(ADX); under these experimental conditions only pronounced increases in MAP and
decreases in iliac vascular conductance (IVC) were observed (Figures 3 & 4). Bilateral
lumbar sympathectomy attenuated the pressor and vasoconstrictor responses observed
in the intact group; however, combined bilateral adrenalectomy plus sympathectomy
(ADX+LX) did not abolish the responses. Instead, relatively large increases in MAP and
decreases in iliac vascular conductance were observed under these conditions. The
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increases in MAP in the ADX+LX group were not different from those observed in intact
animals, whereas iliac vasoconstriction was approximately 4 fold greater in comparison
to the intact group and similar to that observed following EX and ADX (Figure 4). Since
a powerful vasoconstriction persisted after the removal of sympathetic innervation
combined with bilateral adrenalectomy this response must be mediated via unknown
humoral factors released upon stimulation of NTS A1 adenosine receptors. Three major
vasoconstrictor substances may be
released

into

the

circulation under these conditions:
vasopressin,

angiotensin

II

and

600
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IN T
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Figure 4. Integral responses of MAP, IBF, and IVC evoked
by microinjection CPA (330 pmol) into the NTS.
Abbreviations the same as in Figure 3. *Different versus
intact (INT) group (P < 0.05). Reprinted from McClure et al.
2005 (47).

adenosine receptors in the NTS resets the baroreflex control of the circulation to a
higher MAP(71). As previously mentioned the stimulation of NTS A1 adenosine receptors
increases RSNA(76).

The increase in RSNA facilitates the release of renin into the

circulation, which is subsequently transformed into angiotensin II(23). The circulating
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angiotensin II may contribute to the iliac vasoconstriction via AT1 angiotensin receptors.
Finally, since the stimulation of NTS A1 adenosine receptors increases activity of
various sympathetic outputs it is possible that norepinephrine released from synaptic
terminals, other than those directed to the hindlimb, may reach the iliac vascular bed via
circulating blood and contribute to the iliac vasoconstriction. Taking into consideration
that ȕ2-adrenergic receptors, V1 vasopressin receptors, and AT1 angiotensin II receptors
may be differentially expressed in various vascular beds and that regional vascular beds
differentially respond to stimulation/inhibition of those receptors(1; 16; 27-29; 34; 36; 45; 90), the
contribution of neural and humoral factors to regional vascular responses (iliac vs.
mesenteric vs. renal) may likely be different.

Since NTS A1 adenosine receptors

contribute to the pattern of autonomic response to stress/HDR it is especially interesting
if these receptors also contribute to the redistribution of blood from the visceral to
muscle vasculature, which is a key component of stress/HDR-related cardiovascular
adjustments(80-82; 93). All the above hypotheses are addressed in this dissertation.
Experimental plan
During life threatening situations such as stress, hypoxia, ischemia, or severe
hemorrhage, adenosine is released into the central nervous system including the
nucleus tractus solitarii (NTS), a primary integrative center for cardiovascular and other
autonomic reflexes. Selective activation of A1 adenosine receptors in the NTS evokes
inhibition

of

baroreflex

transmission,

differential

regional

sympathoactivation

(adrenal>renallumbar) and variable hemodynamic responses with prevailing pressor
and vasoconstrictor responses. These receptors facilitate the hypothalamic defense
response, and therefore may contribute to the redistribution of blood from the visceral to
the muscle vascular beds. My previous study showed that stimulation of A1 adenosine
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receptors in the NTS triggers in iliac vascular bed E2-adrenergic vasodilation opposed
by vasoconstriction mediated by efferent sympathetic nerves and an unknown
vasoconstrictor factor(s). Therefore, the goal of this dissertation was to identify these
humoral vasoconstrictor(s) and to evaluate the relative role of all vasoactive factors
triggered by NTS A1 adenosine receptors in regional vascular beds.
Aims of dissertation:
1.

To determine which humoral vasoconstrictor(s) (vasopressin, angiotensin II, and
/or norepinephrine) oppose ȕ2-adrenergic vasodilation in the iliac vascular bed
evoked by selective stimulation of A1 adenosine receptors in the NTS.

2.

To determine if A1 adenosine receptor stimulation contributes to the redistribution
of blood flow from visceral (mesenteric and renal) to somatic (iliac) vascular
beds;

specifically,

if

vasoconstrictor

factors

vasodilation in visceral vs. somatic vascular beds.

prevail

over

E2-adrenergic
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CHAPTER 1
Vasopressin is a major vasoconstrictor involved in hindlimb vascular responses
to stimulation of adenosine A1 receptors in the nucleus of the solitary tract
ABSTRACT
Our previous study showed that stimulation of adenosine A1 receptors located in
the nucleus of the solitary tract (NTS) exerts counteracting effects on the iliac vascular
bed: activation of the adrenal medulla and ȕ-adrenergic vasodilation versus
vasoconstriction mediated by neural and unknown humoral factors. In the present study
we

investigated

the

relative

contribution

of

three

major

potential

humoral

vasoconstrictors: vasopressin, angiotensin II and norepinephrine in this response. In
urethane/chloralose anesthetized rats we compared the integral changes in iliac
vascular conductance evoked by microinjections into the NTS of the selective A1
receptor agonist, N6-cyclopentlyadenosine (CPA, 330 pmol in 50 nl) in intact (INT)
animals and following: V1 vasopressin receptor blockade (VX), angiotensin II AT1
receptor blockade (ATX), bilateral adrenalectomy + ganglionic blockade (ADX+GX,
which eliminated the potential increases in circulating norepinephrine and epinephrine),
ADX+GX+VX and ADX+GX+VX+ATX. In INT animals, stimulation of NTS A1 adenosine
receptors evoked typical variable responses with prevailing pressor and vasoconstrictor
effects. VX reversed the responses to depressor ones. ATX did not significantly alter
the responses. ADX+GX accentuated pressor and vasoconstrictor responses whereas
ADX+GX+VX and ADX+GX+VX+ATX virtually abolished the responses. Stimulation of
NTS A1 adenosine receptors increased circulating vasopressin over 4-fold (26.4±10.4
vs. 117.0±19 pg/ml).

These data strongly suggest that vasopressin is a major

vasoconstrictor factor opposing ȕ-adrenergic vasodilation in iliac vascular responses
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triggered by stimulation of NTS A1 adenosine receptors whereas angiotensin II and
norepinephrine do not contribute significantly to the vasoconstrictor responses.
INTRODUCTION
It is now widely accepted that adenosine operating via A1 and A2a receptors
modulates neural cardiovascular control at the level of the nucleus tractus solitarii (NTS)
and other brainstem cardiovascular centers(4;

7; 8; 44; 72; 77; 82; 86)

.

Under normal,

physiological conditions a natural source of adenosine is ATP released synaptically
from neurons as well as from glial cells activated by neighboring neurons(9; 13; 19; 33; 82).
This extracellular ATP is catabolized via ectonucleotidases to adenosine which further
acts more broadly as a neuromodulator operating via pre or postsynaptic A1 and A2a
adenosine receptor subtypes(13;

59; 82; 94)

.

Under pathological conditions such as

ischemia, hypoxia, and severe hemorrhage a global release of adenosine from many
cell types occurs via the breakdown of intracellular ATP(56; 89; 92). Thus, adenosine which
is generated in or released into the extracellular space under physiological or
pathological conditions acts not via specific synapses in specific neuronal pathways but
rather spatially, reaching all adenosine receptor subtypes in the vicinity; this may
resemble signaling via diffusive neurotransmitters/neuromodulators like nitric oxide or
carbon monoxide. This spatial aspect of the action of naturally released adenosine
seems especially important for the NTS where groups of functionally different neurons
usually overlap allowing for "adenosine crosstalk".

Specific physiological effects

exerted via nonselective, spatial spread of adenosine in the NTS may depend on
differential expression of adenosine receptor subtypes on functionally distinct NTS
neurons/terminals, as we suggested previously(72; 77).
In the central nervous system adenosine may inhibit or facilitate release of
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neurotransmitters from synaptic terminals as well as directly inhibit or activate neurons
via pre- and postsynaptic A1 or A2a receptors, respectively(13; 59; 72; 77). Since A1 vs. A2a
adenosine receptors exert contrasting effects on central neurons/terminals reciprocal
effects are usually, although not always, observed in response to selective stimulation
of the two receptor subtypes. NTS A1 adenosine receptor stimulation predominately
yields differential regional sympathoactivation

(adrenal>renallumbar) and pressor

responses(4; 8; 71; 76). In contrast, NTS A2a receptor stimulation typically evokes depressor
responses accompanied by contrasting regional sympathetic responses: decreases in
renal (RSNA), no changes in lumbar (LSNA) and increases in preganglionic adrenal
(pre-ASNA) sympathetic nerve activity(4;

8; 37; 73-75)

. Note that whereas stimulation of

NTS A1 and A2a receptors evoke contrasting changes in RSNA and LSNA, both
adenosine receptor subtypes activate the sympathetic output to the adrenal
medulla(74;76).
Recent

studies

from

our

laboratory

showed

that

the

pressor

and

sympathoexcitatory responses evoked by stimulation of NTS A1 adenosine receptors
are mediated mostly via inhibition of baroreflex mechanisms at the level of the NTS
whereas hemodynamic and differential sympathetic responses evoked by stimulation of
NTS A2a adenosine receptors are mediated mostly via activation of non-baroreflex
mechanisms(37;

71; 74-76)

. It should be stressed that A1 adenosine receptors may also

modulate non-glutamatergic, non-baroreflex mechanisms operating in the NTS. For
example, sinoaortic denervation or ionotropic glutamatergic blockade abolished A1adenosine-receptor-mediated increases in RSNA and LSNA whereas this attenuated,
but did not abolish, the increases in pre-ASNA(76). The activation of pre-ASNA which
persisted after sinoaortic and the glutamatergic blockade was most likely mediated via
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A1 adenosine receptor modulation of non-glutamatergic pathways descending into the
NTS from higher structures, such as from hypothalamic paraventricular and/or
dorsomedial nuclei(26;

65; 87)

. A1 adenosine receptors located on these descending

nonglutamatergic pathways and/or NTS interneurons could selectively activate the
sympathetic output to the adrenal medulla (but not RSNA and LSNA) via disinhibition of
direct NTS-RVLM pathways(20). NTS A1 adenosine receptors may also modulate the
control of heart rate (HR) via both baroreflex and non-baroreflex mechanisms(71;

76)

.

Taken together these observations strongly suggest that A1 adenosine receptors are
differentially located on functionally different NTS neurons/terminals which are mostly,
but not exclusively glutamatergic and involved in the baroreflex arch.
Although selective stimulation of NTS A1 adenosine receptors evokes
predominantly pressor responses(4;

8)

, occasionally biphasic or even depressor

responses are observed(76). This variability of the responses is a natural consequence
of simultaneous activation of at least two counteracting mechanisms: sympathetic
vasoconstriction and E-adrenergic vasodilation mediated via epinephrine released from
the activated adrenal medulla. Since E-adrenergic receptors are preferentially located
in the muscle vascular(90) bed and both pre-ASNA and LSNA increase upon stimulation
of NTS A1 adenosine receptors it was likely that these two counteracting factors may
significantly contribute to the variability of the iliac vascular responses. We confirmed
this hypothesis in our recent study by showing that removal of the vasodilatory
mechanism (via bilateral adrenalectomy as well as peripheral blockade of E-adrenergic
receptors) abolished the variability of the responses normally observed in intact animals
and markedly increased the pressor and hindlimb vasoconstrictor responses(47).

In
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contrast, bilateral lumbar sympathectomy tended to increase the vasodilatory
component of the responses although the variability still persisted. To our surprise,
following combined adrenalectomy plus lumbar sympathectomy a marked, consistent
vasoconstrictor component still persisted suggesting that some unknown humoral
vasoconstrictor factor(s) are involved(47).
The most likely humoral candidates contributing to the iliac vasoconstriction are
vasopressin, angiotensin II and norepinephrine.

Since activation of A1 adenosine

receptors may inhibit glutamate release in baroreflex pathway at the level of the NTS(71;
76)

, and given that the NTS is a crucial, primary relay station for tonic baroreflex

inhibition of vasopressin release(20;

66; 83)

it is likely that the activation of A1 adenosine

receptors may inhibit the baroreflex restraint of vasopressin release. When released,
vasopressin could evoke powerful peripheral vasoconstriction. However, whether A1
adenosine receptors are present on those NTS baroreflex neurons/terminals which
inhibit the release of vasopressin is unknown. The present study was designed to test
this hypothesis.
Since renal sympathetic nerve activity (RSNA) directed to the kidney has been
shown to increase following stimulation of NTS A1 adenosine receptors(76), this may
facilitate the renin/angiotensin mechanism leading to humoral vasoconstriction of the
hindlimb vasculature mediated via AT1 angiotensin II receptors(23). In addition, since
stimulation of NTS A1 adenosine receptors increases the activity of various sympathetic
outputs(76) it is also possible that circulating norepinephrine released from other synaptic
terminals may reach the iliac vasculature and cause vasoconstriction. Therefore, in the
present study we investigated the extent to which these three potential humoral
vasoconstrictors (vasopressin, angiotensin II and/or norepinephrine) contribute to NTS-
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A1-adenosine-receptor-elicited iliac vasoconstriction(47).
MATERIALS AND METHODS
All protocols and surgical procedures employed in this study were reviewed and
approved by the institutional Animal Care and Use Committee and were performed in
accordance with the Guiding Principles in the Care and Use of Animals endorsed by the
American Physiological Society and published by the National Institutes of Health.
Design
This study investigates further the mechanisms responsible for the consistent
variability of hemodynamic responses elicited by activation of adenosine A1 receptors in
the NTS(47; 76). Previously we showed that the variability of the pressor/depressor and
iliac vasoconstrictor/vasodilator responses is not a simple effect of competitive
interactions between sympathetic vasoconstriction vs. ȕ-adrenergic vasodilation but
some unknown, powerful, humoral vasoconstrictor factor(s) are also involved(47).
Therefore, the present study assessed the relative contribution of potential humoral
vasoconstricting factors to the iliac vascular responses evoked by selective stimulation
of NTS A1 adenosine receptors. Experiments were performed on a total of 102 male
Sprague Dawley rats.

In 63 rats we compared the relative vasoconstrictor effects

potentially mediated via vasopressin, angiotensin II, norepinephrine and sympathetic
innervation of the hindquarters, the effects normally opposed by simultaneous ȕadrenergic vasodilation mediated via activation of the adrenal medulla. In an additional
20 rats, respective time controls were performed and in 6 rats the effectiveness of
vasopressin and angiotensin II receptor blockades was assessed. These functional
experiments strongly suggested that the major vasoconstrictor factor triggered by
activation of adenosine A1 receptors in the NTS may be vasopressin. Therefore, in an
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additional group of 13 animals the levels of circulating vasopressin were evaluated
before and following microinjections into the NTS of the selective A1 adenosine receptor
agonist, N6-cyclopentlyadenosine (CPA) or vehicle control.
Instrumentation and measurements
All the procedures were described in detail previously(7; 42; 47; 73-76). Briefly, male
Sprague-Dawley rats (350-400 g, Charles River) were anesthetized with a mixture of Įchloralose (80 mg/kg) and urethane (500 mg/kg, ip), tracheotomized, connected to a
small animal respirator (SAR-830, CWE, Ardmore, PA) and artificially ventilated with
40% oxygen 60% nitrogen mixture. Catheterization of the right femoral artery and vein
were performed to monitor arterial blood pressure and infuse drugs, respectively.
Arterial blood gases were tested occasionally for appropriate experimental values
(Radiometer, ABL500, OSM3).

Averaged values measured at the end of each

experiment were the following: pH = 7.38±0.01, Po2 = 140.1±3.8 mmHg, and Pco2 =
36.2±0.7 mmHg.
From a mid-abdominal incision, the left iliac artery was exposed.

A pulse

Doppler blood flow velocity transducer was placed around the artery and connected to
the flowmeter (Baylor Electronics). From the same mid-abdominal incision in some
animals, bilateral adrenalectomy or lumbar sympathectomy (L1-L6) was performed. The
intermesenteric nerves were also severed in sympathectomized animals.
Arterial blood pressure and iliac flow signals were digitized and recorded with an
analog-digital converter (Modular Instruments) interfaced to a laboratory computer. The
signals were recorded continuously using Biowindows software (Modular Instruments),
averaged over 5 second intervals and stored on hard disk for subsequent analysis.
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Microinjections into the NTS
Animals were placed in stereotaxic frame with head tilted down at 45º. After the
exposure of the brainstem via dissected atlantoccipital membrane, the animals were
allowed to stabilize for at
least

30

min

microinjections.
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Figure 5. Microinjection sites in the caudal subpostremal NTS for all
experiments. Schematic diagrams of transverse sections of the
medulla oblongata from a rat brain. NTS, nucleus tractus solitarii; AP,
area postrema; c, central canal; 10, dorsal motor nucleus of the vagus
nerve; 12, nucleus of the hypoglossal nerve; ts, tractus solitarius; Gr,
gracile nucleus; Cu, cuneate nucleus. Scale is shown at the bottom;
the number on the left side of the schematic diagram denotes the
rostro-caudal position in millimeters of the section relative to the obex
according to the atlas of the rat subpostremal NTS by Barraco et al. (3).
Microinjection sites were marked with fluorescent dye and are denoted
with filled symbols for the pressor responses to CPA and corresponding
open symbols for the depressor responses. A: microinjections of CPA
in intact animals (ʀ,ɿ), after vasopressin V1 receptor blockade (VX) (),
lumbar sympathectomy plus VX (S,U), and after angiotensin II AT1
receptor blockade (ATX) (Ŷ,Ƒ). B: microinjections of CPA after bilateral
adrenalectomy (ADX) plus ganglionic blockade (GX) (T), following
ADX+GX+VX (~), after ADX+GX+VX+ATX (,). In experiments
where vasopressin assay was performed the microinjection sites were
denoted: + and x for CPA and ACF microinjections, respectively.

CPA was dissolved in ACF and the pH adjusted to 7.2. In several previous studies we
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have shown that microinjections of the same amount of ACF into the same site of the
NTS did not markedly affect mean arterial pressure (MAP), HR, RSNA, LSNA and preganglionic adrenal (pre-ASNA) sympathetic nerve activity and vascular flows in iliac,
renal and mesenteric arteries(7; 73-76). The changes in all these variables were either not
different from zero or smaller than natural, random fluctuations of these variables over
the time of measurements.

To avoid the effect of desensitization of A1 adenosine

receptors, in all experiments only one dose of the agonist was microinjected into left or
right side of the NTS. All microinjection sites were marked with fluorescent dye (DiI,
Molecular Probes) and verified histologically (Figure 5) as described previously(7; 42;73-76).
We believe that the microinjection technique mimics natural, spatial (not strictly
synaptic) action of adenosine in the central nervous system as adenosine is naturally
produced in the intracellular space by ectonucleotidases from extracellular ATP
(released from neurons and glial cells under physiological conditions)(9; 13; 33; 82; 94) or it is
directly released into the intracellular space from ischemic/hypoxic neurons and glial
cells under pathological conditions(56; 89; 92).
Experimental protocols
In a previous study from our laboratory we showed that in addition to sympathetic
iliac

vasoconstriction

and

E-adrenergic

vasodilation

some

unknown

humoral

vasoconstrictor(s) contribute to the consistent variability of hemodynamic responses
evoked by selective stimulation of adenosine A1 receptors located in the NTS(47). This
conclusion was based on comparing of the responses observed in intact animals and
following four experimental protocols: 1) E-adrenergic blockade, 2) adrenalectomy, 3)
lumbar sympathectomy and 4) combined adrenalectomy plus lumbar sympathectomy.
In the last experimental condition a powerful iliac vasoconstriction was observed
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indicating that non-sympathetic, humoral vasoconstrictors are involved(47). The present
study is a direct extension of our previous findings and focuses on the relative
contribution to the responses of three potential humoral vasoconstrictors: vasopressin,
angiotensin II and norepinephrine.
Six experimental protocols were
designed,

according

to

the

diagrams presented in Figure 6.
Data collected in each protocol
were compared with responses
observed

in

intact

group.

In

Protocols 1 and 2 the contribution
of vasopressin and angiotensin II
was
Figure 6.
Time line of how experimental protocols are
executed: vasopressin V1 receptor blockade (VX), lumbar
sympathectomy + V1 receptor blockade (LX+VX), angiotensin II
AT1 receptor blockade (ATX), bilateral adrenalectomy +
ganglionic blockade (ADX+GX), adrenalectomy + ganglionic
blockade + V1 receptor blockade (ADX+GX+VX) and
adrenalectomy + ganglionic blockade + V1 receptor blockade +
AT1 receptor blockade (ADX+GX+VX+ATX).
Time control
experiments were performed for protocols including ATX and/or
GX (protocols 2-5) according to the respective diagrams;
however microinjections of CPA were omitted.

assessed

by

comparing

hemodynamic responses elicited
by

stimulation

adenosine
animals

of

receptors
with

those

NTS
in

A1
intact

obtained

following selective blockade of

vasopressin V1 receptors and angiotensin II AT1 receptors via iv. injections of selective
antagonists:

2

[ȕ-mercapto-ȕ,ȕ-cyclopentylmethylenepropionyl,1-O-Me-Tyr ,Arg8]-

vasopressin, (20 ȝg/kg, Sigma) and losartan (5 mg/kg, Merck Inc.), respectively. To
evaluate the potential contribution of circulating norepinephrine to the responses
ganglionic blockade (hexamethonium bromide, 25 mg/kg iv, Sigma) was combined with
adrenalectomy (Protocol 3) and these data and the responses observed previously
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following adrenalectomy alone(47) are discussed together. This indirect evaluation of
norepinephrine contribution to the responses was necessary because total sympathetic
denervation is impossible and ganglionic blockade, which prevents secretion of
norepinephrine from sympathetic terminals, also impairs/abolishes the effects of
activation of the adrenal medulla; thus ganglionic blockade removes E-adrenergic
vasodilation simultaneously.

Therefore, the appropriate reference point for the

responses obtained following the ganglionic blockade (Protocol 3) were the responses
obtained following adrenalectomy alone which has been already performed in our
previous study(47). Protocol 4 removed the combined contribution of norepinephrine and
vasopressin to the responses (ganglionic blockade + vasopressin V1 receptor blockade)
whereas Protocol 5 removed the combined effect off all three potential vasoconstrictors
considered via ganglionic blockade + vasopressin V1 receptor blockade + angiotensin
AT1 receptor blockade. Protocols 3-5 were performed in adrenalectomized animals to
clarify the experimental conditions by removing any residual adrenal responses which
may potentially persist following the ganglionic blockade. Since preliminary results of
the above five experimental protocols strongly suggested that only vasopressin has a
marked contribution to the responses, in Protocol 6 the magnitude of E-adrenergic
vasodilation alone, not opposed by major vasoconstrictor factors (sympathetic
vasoconstriction and vasopressin) was assessed. In this protocol bilateral lumbar
sympathectomy was combined with blockade of V1 vasopressin receptors and these
data were compared with data following V1 vasopressin receptor blockade alone
(Protocol 1) and discussed together with previous data obtained following bilateral
lumbar sympathectomy alone(47).
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The effectiveness of vasopressin V1 and angiotensin AT1 receptor blockades
were tested in separate groups of animals (n=3 for each blockade) with iv injections of
arginine-vasopressin (50 mU/kg, Sigma) and angiotensin II (300 ng/kg, Sigma),
respectively, before and after the blockade. Both blockades remained effective for over
Table 1. Maximal hemodynamic responses evoked by blockade of V1 vasopressin receptors (VX), AT1
angiotensin II receptors (ATX) and ganglionic blockade (GX).

Experimental groups

n

VX
GX
ATX

16
39
15

¨% Mean Arterial
Pressure, mmHg
-4.7±1.8#
-39.7±1.9#
-49.2±2.8#

¨% Heart Rate,
beats/min
1.2±0.9
3.1±1.9
-13.9±3.5#

¨% Iliac vascular
Conductance
15.3±2.7#
99.9±9.9#
125.1±18.2#

¨% Iliac Blood Flow
10.2±1.6#
16.6±3.3#
8.6±6.1

#

Data are means r SE. P<0.05 vs. zero. Numbers of responses to VX, GX and ATX were combined from those protocols
where these blockades were applied as a first pharmacological manipulation: nVX = nVX + nLX+VX; nGX = nADX+GX + nADX+GX+VX
+ nADX+GX+VX+ATX + n of respective controls; nATX = nATX + n of respective control (see Table 2). The small changes in mean
arterial pressure and iliac vascular conductance caused by VX were allowed to return spontaneously toward resting levels,
whereas the large, sustained changes in these variables caused by ATX and GX were compensated via iv infusion of
phenylephrine (see Table 1).

1 hour. Blockade of V1 vasopressin receptors caused relatively small decreases in
MAP and increases in IVC (Table 1) which spontaneously returned toward resting
values

in

approximately

10

min;

therefore

approximately

10

min

after

V1

Table 2. Infusion rates of phenylephrine used to maintain mean arterial pressure and iliac vascular
conductance at pre-blockade levels in experimental and respective time control groups in which angiotensin
AT1 receptor blockade (ATX) and/or ganglionic blockade (GX) were performed.

Protocol
number
2
3
4
5

Experimental procedure

n

ATX
ADX + GX
ADX + GX + VX
ADX + GX + VX + ATX

10
8
8
8

#

Infusion rate
ml/h/kg
3.18±0.12*
3.02±0.24*
3.45±0.41*
6.33±0.24

Time controls

n

ATX
ADX + GX
ADX + GX + VX
ADX + GX + VX + ATX

5
5
5
5

Infusion rate
ml/h/kg
2.39±0.25*
3.20±0.33*
3.94±0.62
5.29±0.62

Data are means r SE. P<0.05 vs. zero. Numbers of responses to VX, GX and ATX were combined from those protocols
where these blockades were applied as a first pharmacological manipulation: nVX = nVX + nLX+VX; nGX = nADX+GX + nADX+GX+VX
+ nADX+GX+VX+ATX + n of respective controls; nATX = nATX + n of respective control (see Table 2). The small changes in mean
arterial pressure and iliac vascular conductance caused by VX were allowed to return spontaneously toward resting levels,
whereas the large, sustained changes in these variables caused by ATX and GX were compensated via iv infusion of
phenylephrine (see Table 1).
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vasopressinergic blockade the microinjection of CPA was performed in Protocols 1 and
6 (Figure 6). However, following blockade of angiotensin AT1 receptors and ganglionic
blockade marked and sustained decreases in MAP and increases in IVC were observed
(Table 1).

Therefore, in Protocols 2-5, where these blockades were performed iv

infusions of phenylephrine (PE, Sigma, 200 Pg/ml) were used to return the
hemodynamic
toward

baseline,
blockade
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MAP (mmHg)
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Figure 7. An example of time control experiment following adrenalectomy plus
ganglionic blockade (GX) plus vasopressin blockade (VX) plus angiotensin II AT1
receptor blockade (ATX); no CPA was microinjected in this experiment. The
dashed arrow denotes a potential microinjection of CPA and the subsequent 20
min integration of the response. Note that although the infusion of phenylephrine
(PE) did not fully compensated for the decrease in mean arterial pressure (MAP)
the iliac vascular conductance (IVC) gradually declined constricting iliac

between Protocols 2-4. However, significantly greater PE infusion rates were required
when angiotensin AT1 receptor antagonists, losartan, were combined with ganglionic
and V1 vasopressin receptor blockades in Protocol 5 (Table 2). During the responses to
stimulation of NTS A1 adenosine receptors PE infusion was continued at the same rates
as needed to compensate for the altered hemodynamic values in Protocols 2-5. The
effect of PE infusion on baseline hemodynamic values was estimated in respective time
controls for Protocols 2-5 (Table 2). In the time-control experiments all procedures
except microinjections of CPA were performed in the same time-pattern as in
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experimental Protocols 2-5. Figure 7 shows an example of a time control for the most
complex experimental Protocol 5. PE infusion rates were similar in the experimental
protocols and respective time controls (Table 2).
Vasopressin assay
Since the hemodynamic experiments (Protocols 1-6) suggested that vasopressin
plays a dominant role in the iliac vascular responses to stimulation of NTS A1 adenosine
receptors, in an additional group of animals the effect of microinjections into the NTS of
CPA (n=8) or respective volume control (50 nl of ACF, n=5) on circulating vasopressin
were evaluated. We compared the levels of plasma vasopressin measured 30 min
before and ~8 min after the microinjections (the average time when maximal
hemodynamic responses to stimulation of NTS A1 receptors occur).

Arterial blood

samples (~1 ml) were slowly withdrawn from the femoral artery into prechilled,
heparinized tubes. Blood volume was kept unchanged via simultaneous infusion of the
same volume of donor blood into the femoral vein. The samples were immediately
placed on ice and centrifuged at 5000 g for 10 min at 4º C. Plasma was collected and
stored at -70º C.

Plasma vasopressin concentration was assessed via standard

radioimmunoassay procedures in our laboratory as described previously(32; 54; 61). The
sensitivity of the vasopressin assay was 0.1 pg/ml and 50% displacement was 4.1
pg/tube. Intra- and inter-assay variability was 7.0% and 13.4%, respectively.
Data analysis
Hemodynamic responses were analyzed over a 20 min period following the
microinjections, similar to our previous study(47). The responses were quantified as an
integration of the differences between the baseline and response values averaged in 1
min periods and summed for 20 min of the response, i.e. when the majority of the
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responses occur. The integral reflects the predominant trend of the responses despite
transient, sometimes large, bidirectional fluctuations in each variable.

Because

hemodynamic effects evoked by stimulation of NTS A1 adenosine receptors were
variable, often biphasic, or even polyphasic, as we previously reported(47; 76), we used
the integral values for the comparison between the experimental groups. The absolute
values of blood flow depend to some extent on positioning of the probe around the iliac
artery; therefore the comparison between the relative changes in MAP, IBF, and IVC
were more reliable. The HR responses, calculated from pulse intervals through the flow
probe, were expressed in absolute values (beats/min). Iliac vascular conductance (IVC)
was calculated by dividing iliac blood flow (IBF), expressed as a Doppler shift (in Hz) by
MAP (in mmHg). In experimental Protocols 2-5, where PE was infused to compensate
for the decreased MAP and increased IVC the direct effect of PE on baseline
hemodynamic variables was evaluated in respective time control experiments and
subtracted from experimental data. Specifically, changes occurring in each variable
during time-control experiments were integrated for 20 min and subtracted from the
respective 20 min integral values obtained in each animal of the experimental groups
(Protocols 2-5).
One-way ANOVA for independent measures was used to compare hemodynamic
responses versus experimental conditions.

Differences observed were further

evaluated by t-test with Bonferroni adjustment for independent measures. Differences
between circulating vasopressin levels measured before and after microinjections of
ACF or CPA were evaluated using paired t-test; the differences in vasopressin levels
between the groups (ACF vs. CPA) were evaluated using unpaired t-test. The changes
in all recorded variables were also compared with zero by means of SYSTAT univariate
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F test. An Į level of P < 0.05 was used to determine statistical significance.
Table 3. Resting values of hemodynamic parameters in each experimental group.
Protocol
number
1
2
3
4
5
6
(2)
(3)
(4)
(5)

Experimental procedure

n

Mean Arterial
Pressure, mmHg

Heart Rate,
beats/min

Iliac Blood Flow,
Hz

INTACT
VX
ATX
ADX + GX
ADX + GX + VX
ADX + GX + VX + ATX
LX + VX
Control
(ATX)
Control
(ADX + GX)
Control
(ADX + GX + VX)
Control
(ADX + GX + VX + ATX)

13
8
10
8
8
8
8

98.1±.1
105.3±4.9
95.3±4.9
93.1±5.1
88.7±1.3
88.1±2.1
95.8±4.1

353.9±4.7
359.7±11.2
342.2±8.2
383.6±11.4
383.3±9.0
405.0±10.9*
340.6±7.0

1030.2±3.6
1091.0±204.2
992.8±122.5
1190.4±167.2
1394.0±222.7
1271.0±102.9
1336.4±132.8*

Iliac Vascular
Conductance,
Hz/mmHg
10.9±3.3
10.6±2.0
10.8±1.5
13.2±2.1
15.8±2.7
14.4±1.1
14.3±1.7

5

99.3±2.8

330.0±11.8

973.7±173.2

10.0±2.0

5

84.2±2.8

365.8±17.2

1073.1±144.7

12.8±1.8

5

88.1±3.5

381.6±7.8

1121.6±141.1

12.7±1.4

5

90.2±4.7

398.9±13.3

1144.6±302.0

12.2±2.4

Data are means r SE; n=number of rats. Numbers in parentheses show time controls for respective protocols.
Resting values for intact animals and following: vasopressin V1 receptor blockade (VX), angiotensin II AT1 receptor
blockade (ATX), bilateral adrenalectomy + ganglionic blockade (ADX+GX), adrenalectomy + ganglionic blockade
+ V1 receptor blockade (ADX+GX+VX), adrenalectomy + ganglionic blockade + V1 receptor blockade + AT1
receptor blockade (ADX+GX+VX+ATX) and lumbar sympathectomy + V1 receptor blockade (LX+VX). . * P<0.05
vs. Intact

RESULTS
Resting values of MAP, HR, IBF and IVC for each experimental group, measured
just before stimulation of NTS A1 adenosine receptors, are presented in Table 3. The
resting MAP and IVC for all the groups where blockades were performed were not
different from those for intact animals; this provided reliable comparison between the
experimental protocols. The direct effects of ganglionic blockade, and blockade of V1
vasopressin and AT1 angiotensin II receptors on all hemodynamic variables are
presented in Table 1. The large decreases in MAP and increases in IVC evoked by
blockade of AT1 angiotensin II receptors and/or ganglionic blockade required additional
compensation with PE, whereas the small decreases in MAP and increases in IVC
evoked by V1 vasopressin receptor blockade were allowed to partially recover without
compensation.
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Effects of V1, AT1 and ganglionic blockades on responses to stimulation of NTS A1
adenosine receptors
Figure 8 presents examples of the responses evoked by selective stimulation of
NTS A1 adenosine receptors which were observed most often under each experimental
condition. The average integral responses for each experimental group are presented

VX

MAP (mmHg)

INT
200

CPA

ATX
CPA

CPA

ADX
+GX
+VX
+ATX

ADX
+GX
+VX

ADX
+GX
CPA

CPA

CPA

150
100
50
0

IBF (Hz)

200
150
100
50
0

IVC
(Hz/mmHg)

200
150
100
50
0
0

25
TIME(min)

50

0

25
TIME(min)

50

0

25
TIME(min)

50

0

25
TIME(min)

50

0

25
TIME(min)

50

0

25

50

TIME(min)

Figure 8. Mean arterial pressure (MAP), iliac blood flow (IBF) and iliac vascular conductance (IVC)
responses to microinjection of adenosine A1 receptor agonist (CPA, 330 pmol/50 nl) into the
subpostremal NTS in intact rats (INT) and following: vasopressin V1 receptor blockade (VX),
angiotensin II AT1 receptor blockade (ATX), bilateral adrenalectomy + ganglionic blockade
(ADX+GX), adrenalectomy + ganglionic blockade + V1 vasopressin receptor blockade
(ADX+GX+VX) and adrenalectomy + ganglionic blockade + V1 vasopressin receptor blockade + AT1
angiotensin II receptor blockade (ADX+GX+VX+ATX). Microinjections of CPA, marked by vertical
arrows, were applied ~10 -20 min after the blockades, when baseline levels of all variables stabilized
(see Figure 6). Note that VX reversed pressor and vasoconstrictor responses most often observed
in INT group into depressor and vasodilatory responses. ADX+GX exaggerated the pressor and
vasoconstrictor response. These exaggerated vasoconstrictor responses were virtually abolished
following ADX+GX+VX and ADX+GX+VX+ATX.
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Figure 9. Integral responses of MAP, IBF and IVC
evoked by microinjections of CPA (330 pmol /50 nl)
into the caudal subpostremal NTS. Abbreviations
as in Figure 8. Data are means ± SE. In groups
ATX, ADX+GX, ADX+GX+VX, ADX+GX+VX+ATX
respective time control values were subtracted. *,
different versus intact group (P<0.05). #, different
versus zero (P<0.05).
VX reversed iliac
vasoconstrictor responses observed in intact group
into vasodilation and virtually abolished exaggerated
vasoconstrictor responses observed following
ADX+GX.
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Table 4. Number of individual experiments where overall increments or decrements were observed for
each recorded hemodynamic parameter based on its integral values

Protocol
number

Experimental procedure

n

1
2
3
4
5
6

INTACT
VX
ATX
ADX + GX
ADX + GX + VX
ADX + GX + VX + ATX
LX + VX

13
8
10
8
8
8
8

Mean Arterial
Pressure, mmHg
Incr
10
0
9
8
5
7
1

Decr
3
8
1
0
3
1
7

iliac

Heart Rate,
beats/min
Incr
1
0
4
1
2
2
1

Decr
12
8
6
7
6
6
7

Iliac Blood Flow,
Hz
Incr
1
3
2
0
0
1
5

Decr
12
5
8
8
8
7
3

Iliac Vascular
Conductance,
Hz/mmHg
Incr
Decr
1
12
7
1
0
10
0
8
1
7
0
8
8
0

Number of increments (Incr) and decrements (Decr) observed in intact animals and following: vasopressin V1
receptor blockade (VX), angiotensin II AT1 receptor blockade (ATX), bilateral adrenalectomy + ganglionic blockade
(ADX+GX), adrenalectomy + ganglionic blockade + V1 receptor blockade (ADX+GX+VX), adrenalectomy +
ganglionic blockade + V1 receptor blockade + AT1 receptor blockade (ADX+GX+VX+ATX), and lumbar
sympathectomy + V1 receptor blockade (LX+VX).

35
intact group into slight iliac vasodilation (P=0.0001 vs. intact). Blockade of angiotensin
II AT1 receptors alone did not significantly alter the responses in comparison to the
intact group (P>0.05 for all variables). Elimination of adrenal and sympathetic neural
effects on the iliac vasculature (Protocol 3) increased the iliac vasoconstrictor
responses almost 4-fold in comparison to the intact group indicating that other humoral
factor(s) different than circulating norepinephrine play a crucial role in the iliac
vasoconstrictor responses. Subsequent blockade of vasopressin V1 receptors (Protocol
4) virtually abolished the exaggerated iliac vasoconstriction observed following
adrenalectomy plus ganglionic blockade alone (Protocol 3) (Figures 8 and 9) indicating
that the humoral iliac vasoconstriction evoked by stimulation of NTS A1 adenosine
receptors is mediated mostly via the release of vasopressin. Combined blockade of
neural and all considered humoral factors (adrenalectomy + ganglionic + V1
vasopressinergic + AT1 angiotensinergic blockades, Protocol 5) had very similar effects
on the responses to that observed in Protocol 4 (adrenalectomy + ganglionic + V1
vasopressinergic blockades); there were no significant differences between these two
groups with respect to MAP, HR and IVC responses (P>0.05 for all comparisons). The
lack of differences between responses observed in Protocols 4 and 5 additionally
confirmed that vasopressin is the dominant humoral vasoconstrictor factor triggered by
stimulation of NTS A1 adenosine receptors. The analysis of absolute values of the
integral responses presented in Table 5 leads to the same conclusions as those based
on the relative responses (Figure 9). The absolute values of the responses, presented
in Table 5, show residual iliac vasoconstrictor effects in Protocols 4 and 5. However,
this vasoconstriction was abolished when the respective time control values were
subtracted from the direct experimental values presented in Table 5.
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Table 5. Absolute values of integral changes in MAP, HR, IBF and IVC evoked by microinjections of CPA (330
pmol in 50 nl) into the NTS in each experimental group.

Protocol
number
1
2
3
4
5
6
(2)
(3)
(4)
(5)

Experimental procedure

n

Mean Arterial
Pressure, mmHg

Heart Rate,
beats/min

Iliac Blood Flow,
Hz

INTACT
VX
ATX
ADX + GX
ADX + GX + VX
ADX + GX + VX + ATX
LX + VX
Control
(ATX)
Control
(ADX + GX)
Control
(ADX + GX + VX)
Control
(ADX + GX + VX + ATX)

13
8
10
8
8
8
8

86.0±37.7#
-195.2±63.9*#
#
198.4±47.3
312.3±67.1*#
7.1±46.3
74.9±19.0#
-162.0±71.5*#

-379.3±96.4#
-411.9±99.3#
-70.6±126.0
-139.0±48.6#
-237.0±137.5
-249.8±134.8
-502.0±177.3#

-1480.3±588.7#
59.6±784.5
#
-1585.8±445.4
-5758.2±1284.4*#
-2752.3±715.7#
-1784.9±447.1#
2127.6±1489.5*

Iliac Vascular
Conductance,
Hz/mmHg
-23.1±7.1#
20.8±9.3*#
#
-34.8±6.4
-91.6±20.2*#
-31.3±11.5#
-30.9±5.5#
57.5±11.4*#

5

80.0±37.6

504.1±91.8*

#

-303.2±573.6

-9.8±3.6

5

22.3±36.2

54.5±104.8*

-166.1±364.4

-5.9±3.8

5

15.6±39.7

163.3±54.5*

#

-1224.1±380.7

-13.8±5.1

5

-11.4±23.7

206.5±61.6*#

-2694.9±1428.2

-24.7±13.0

#

#

#

#

Data are means r SE. * P<0.05 vs. Intact; P<0.05 vs. zero. Numbers in parentheses show time controls for respective
protocols. Integral changes for intact animals and following: vasopressin V1 receptor blockade (VX), angiotensin II AT1 receptor
blockade (ATX), bilateral adrenalectomy + ganglionic blockade (ADX+GX), adrenalectomy + ganglionic blockade + V1 receptor
blockade (ADX+GX+VX),
adrenalectomy + ganglionic blockade + V1 receptor blockade + AT1 receptor blockade
(ADX+GX+VX+ATX), and lumbar sympathectomy + V1 receptor blockade (LX+VX).

Data collected in Protocols 1-5 (Figures 4 and 5) strongly suggested that the only
significant humoral vasoconstrictor contributing to iliac vascular responses evoked by
selective stimulation of NTS A1 adenosine receptors is vasopressin. Therefore, in
Protocol 6 vasopressin and lumbar sympathetic vasoconstrictor components of the
responses were eliminated to unmask E-adrenergic vasodilation alone, not opposed by
neural and humoral vasoconstriction.

Following V1 vasopressin receptor blockade

combined with bilateral lumbar sympathectomy (Protocol 6) the iliac vasodilation
response doubled in comparison to that observed following V1 vasopressin receptor
blockade alone (405.1± 58.4³'% vs. 195.8±51.2³'%, P=0.0175).
The above observations are supported by comparison of the frequency of which
we observed increases vs. decreases in hemodynamic variables in each experiment for
all experimental groups (Table 4).

In intact animals, decreases in IVC prevailed
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whereas following V1 vasopressinergic blockade the increases in IVC prevailed.
Combined V1 vasopressinergic blockade and lumbar sympathectomy completely
eliminated iliac vasoconstrictor responses (Protocol 6). AT1 angiotensinergic blockade
increased the number of pressor and vasoconstrictor events in comparison to the INT
group (Table 4), although there were no significant differences between the averaged
responses observed in this vs. intact groups (Figure 9). Adrenalectomy plus ganglionic
blockade completely eliminated the depressor and iliac vasodilatory responses as
expected (Protocol 3).

When V1 vasopressinergic blockade was added to

adrenalectomy and ganglionic blockade (Protocol 4) or all the blockades were
performed

in

adrenalectomized

animals

(Protocol

5)

again

variable

vasoconstrictor/vasodilatory responses were observed; however, this variability
reflected rather random variations of IVC as vascular responses were virtually abolished
in these groups (changes in IVC were not different from zero, Figure 9). Prevailing
pressor and depressor responses were consistent with prevailing vasoconstrictor and
vasodilatory responses in each experimental group. However, the decreases in HR
dominated in all experimental groups despite the different experimental conditions.
Release of vasopressin in response to stimulation of NTS A1 adenosine receptors
The above results, obtained via pharmacological blockade approaches, strongly
suggested that vasopressin is a dominant vasoconstrictor factor released into the
circulation following the selective stimulation of NTS A1 adenosine receptors.
Therefore, in an additional two groups of animals we tested this hypothesis more
directly by measuring whether the plasma levels of vasopressin indeed increase as a
result of stimulation of NTS A1 adenosine receptors (Figure 10). The resting levels of
vasopressin were similar in both groups (P=0.931) and they were moderately elevated

in comparison to vasopressin
levels normally observed in
intact conscious animals(12;
35; 53; 54)

consistent with levels

associated
and

32;

with

stress(12;

surgical

Stimulation
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Figure 10. Comparison of plasma vasopressin levels measured
before (Pre) and after (Post) microinjections into the NTS of vehicle
(ACF, n=5) or selective A1 adenosine receptor agonist (CPA, n=8).
*, differences between pre- vs. post-microinjections (P<0.05); #,
differences between the groups (P<0.05). CPA increased
circulating vasopressin levels 4-fold whereas ACF did not
significantly increase the level of circulating vasopressin.

NTS also tended to increase the level of circulating vasopressin; however the increase
did not reach statistical significance (P=0.083).

Notably the difference between

vasopressin levels measured across the groups, i.e. following microinjections of CPA
vs. ACF was also significant (P=0.041).
DISCUSSION
The present study assessed the relative roles of three major humoral
vasoconstricting factors in mediating the responses to stimulation of A1 adenosine
receptors located in the NTS. The release of humoral vasoconstrictor factor(s) had been
implied by our previous study which showed that the large iliac vasoconstriction,
triggered by stimulation of NTS A1 adenosine receptors, persisted after bilateral lumbar
sympathectomy and adrenalectomy(47). The major finding of the present study is that
vasopressin is released into the circulation upon stimulation of NTS A1 adenosine
receptors and that it is the primary humoral factor contributing to the iliac
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vasoconstriction. The potential release of norepinephrine and angiotensin II did not
contribute significantly to the iliac vascular responses.
NTS A1 adenosine receptors are involved in control of vasopressin release
Our previous studies strongly suggested that A1 adenosine receptors may
modulate vasopressin release at the level of the NTS similarly as they modulate
baroreflex control of regional sympathetic outputs and HR(71; 76). However, considering
differential localization/expression of adenosine receptor subtypes on functionally
different NTS neurons(72; 77), it remained unknown if A1 adenosine receptors are indeed
located on these baroreflex neurons controlling vasopressin release. The present study
showed that activation of A1 adenosine receptors in the NTS disinhibits vasopressin
release. Therefore, pre- and/or postsynaptic A1 adenosine receptors are likely located
on those NTS baroreflex neurons/terminals which control vasopressin release. This
hypothesis based on integrative, systemic data may be confirmed in future studies at
the cellular level.
The most likely mechanism responsible for the release of vasopressin into the
circulation in response to stimulation of NTS A1 adenosine receptors is the inhibition of
baroreflex transmission in the NTS resulting in the disinhibition of vasopressin release
from hypothalamic nuclei (paraventricular and supraoptic)(20).

The role of NTS in

baroreflex control of vasopressin release has been well established(66;

83)

. Bilateral

inhibition, anesthetization or lesioning of the NTS, which removes baroreflex
mechanisms, results in 10-fold increases of circulating vasopressin levels and
vasopressin-mediated hypertension(83). Sinoaortic baroreceptor denervation prevents
this response(66).

In the present study the unilateral inhibition of NTS baroreflex

mechanisms via unilateral activation of A1 adenosine receptors resulted in 5-fold
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increases in circulating vasopressin.
Relative roles of vasoactive factors triggered by activation of A1 adenosine receptors in
the NTS
Our previous study showed that activation of A1 adenosine receptors in the NTS
evokes

neural

and

humoral

iliac

vasoconstriction

opposed

by

E-adrenergic

vasodilation(47). The counteracting vascular effects contributed to the variability of the
overall pressor/depressor responses with prevailing vasoconstriction and increases in
MAP.

These conclusions were based on comparison of iliac vascular responses

observed

in

intact

animals

and

following

E-adrenergic

blockade,

bilateral

adrenalectomy, lumbar sympathectomy and combined adrenalectomy plus lumbar
sympathectomy.

The present study investigated potential humoral vasoconstrictors

(vasopressin, angiotensin II and norepinephrine) by assessing the effects of
vasopressin V1 receptor and angiotensin AT1 receptor blockade as well as ganglionic
blockade performed in adrenalectomized animals. Perhaps the most compelling results
were that the blockade of peripheral V1 vasopressin receptors reversed the normal iliac
vasoconstriction into marked vasodilation. This vasodilation was further enhanced by
adding lumbar sympathectomy to the V1 receptor blockade. It is likely that sympathetic
nerves have a smaller role than vasopressin in mediating this iliac vasoconstriction as
lumbar sympathectomy alone, performed in our previous study(47), had a relatively
smaller effect on the IVC responses then V1 vasopressinergic blockade alone,
performed in the present study. Collectively, these data indicate that vasopressin alone
can override epinephrine induced iliac vasodilation and induce vasoconstriction, but that
sympathetic nerves alone do not. The roles of vasopressin and sympathetic nerves
appear additive as the sum of the individual effects approximate that of the combined
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effects.

Vasopressin together with increases in LSNA can induce significant

vasoconstriction without which a powerful E adrenergic vasodilation is revealed. We
conclude that the variability often seen in the arterial pressure response to A1 receptor
stimulation is the direct result of these “push-pull” counteracting mechanisms.
Circulating norepinephrine potentially released upon stimulation of NTS A1
adenosine receptors likely has little role as ganglionic blockade did not lessen the
intense iliac vasoconstriction seen after bilateral adrenalectomy(47).

Probably the

amount of norepinephrine released from sympathetic terminals was too small to exert
measureable effects beyond that of circulating norepinephrine already likely to be
elevated as a result of anesthesia and surgical stress.

A previous study from our

laboratory showed that pre-ASNA increased much more than RSNA and LSNA in
response to stimulation of NTS A1 adenosine receptors(76). It is possible that other
sympathetic outputs responded even less or might even be inhibited with the
stimulation. This could cause the increase of circulating norepinephrine in the present
study to be functionally irrelevant.
Angiotensin II blockade alone markedly decreased baseline MAP and increased
IVC. However the normal pressor and vasoconstrictor responses to microinjections of
CPA did not decrease but rather tended to increase. This indicates that angiotensin II,
similarly as circulating norepinephrine, does not contribute to the iliac vasoconstriction
elicited by stimulation of NTS A1 adenosine receptors. Although increases of RSNA
may cause an increase in the release of renin from the kidney(23), the total time from
activation of the renal nerve to the subsequent release of renin and conversion of
angiotensinogen to angiotensin I and then to angiotensin II may have exceeded the time
of the analyzed responses. In addition, losartan used to block AT1 receptors in this
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study most likely crossed the blood-brain barrier and might evoke central effects
counteracting the peripheral actions. Nevertheless, our data show that circulating
angiotensin II had no functional effect as a potential humoral iliac vasoconstrictor
triggered by stimulation of NTS A1 adenosine receptors.
Vasoactive effects of NTS A1 vs. A2a adenosine receptor subtypes
The predominately pressor but often variable responses to selective stimulation
of NTS A1 adenosine receptors are mediated most likely via inhibition of baroreflex
glutamatergic transmission in the NTS and resetting of baroreflex functions toward
higher MAP(71;

76)

. In contrast, selective stimulation of NTS A2a adenosine receptors

evokes decreases in MAP and preferential iliac vasodilation mediated via nonbaroreflex, nonglutamatergic mechanism(s)(37;

74; 75)

. These responses were mediated

mostly via activation of the adrenal medulla and E-adrenergic mechanism and to a
lesser extent via lumbar sympathetic nerves(42).

However, no other humoral

mechanisms were involved as bilateral adrenalectomy and lumbar sympathectomy
abolished the responses(42). How do these two adenosine receptor subtypes contribute
to the responses mediated by adenosine operating in the NTS under physiological(19; 82)
or pathological(56; 78; 89; 92) conditions? It is well known that microinjections of adenosine
into the NTS results in depressor responses similar to those observed following
selective activation of A2a adenosine receptors(6;

51; 85)

.

However, both adenosine

receptor subtypes may contribute to the depressor responses as they both activate the
adrenal medulla and facilitate E-adrenergic vasodilation via baroreflex and unknown,
non-baroreflex mechanisms(74; 76). Other components of the responses elicited by NTS
A2a receptors (decreases in RSNA and HR) may further contribute to the depressor
responses, whereas A1 receptor-mediated sympathoactivation and vasopressin release
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would oppose these responses.

Under physiological conditions adenosine may

contribute to the pressor effects evoked by stimulation of the hypothalamic defense
area(19;

82)

via A1 receptor-mediated inhibition of baroreflex mechanisms and resulting

sympathoactivation and vasopressin release(71;

76)

.

In contrast, under pathological

conditions naturally released adenosine, acting via both A1 and A2a adenosine receptor
subtypes, may contribute to the paradoxical sympathoinhibition and cardiac slowing
observed during hypovolemic phase of hemorrhagic shock(78).
Limitations of the method
In the central nervous system adenosine is not released synaptically, but rather
produced in the extracellular space via the degradation of ATP which is released at
synaptic terminals from neurons as well as released from glial cells activated by
extracellular glutamate diffused from nearby active nerve terminals(9;

13; 33; 94)

. In

addition, under pathological conditions adenosine is released into the extracellular
space in a global, non-synaptic manner from hypoxic/hypoperfused neurons and glial
cells(56; 56; 89; 92). Therefore the natural, spatial (not strictly synaptic) action of adenosine
in the NTS, may be simulated well via microinjections of selective agonists of adenosine
receptor subtypes. Importantly, although adenosine is released non-selectively in the
NTS, it does produce specific differential responses in regional sympathetic outputs and
vascular beds as shown by numerous studies from our laboratory(7; 71; 73-76). We believe
that these specific, differential effects evoked by nonspecific, spatial activation of
adenosine receptors result from differential location/expression of adenosine receptor
subtypes on NTS neurons and synaptic terminals controlling different sympathetic
outputs and involved in different mechanisms integrated in the NTS(72; 77). To confirm
this hypothesis, based on systemic, integrative approaches, further studies at the
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cellular level are required.
The experiments were performed in anesthetized animals and these conditions
most likely attenuated baroreflex mechanisms which may have contributed to the
increased vasopressin levels. In the conscious rat circulating vasopressin level is ~ 2
pg/ml(12; 32; 35; 53; 54; 61). With even limited surgery under anesthesia baseline vasopressin
rises to ~6-10 pg/ml(12; 35; 66; 83). In our study after extensive surgery under anesthesia
baseline vasopressin levels were ~25 pg/ml. However, despite the increased baseline
vasopressin levels, activation of NTS A1 adenosine receptors triggered marked release
of vasopressin into the circulation (Figure 10) and a powerful V1 receptor mediated
vasoconstrictor effect in the hindlimb vasculature was apparent (Figure 9). In contrast,
no functional effects of potential, A1-adenosine-receptor-mediated increases in
circulating norepinephrine or angiotensin II were observed.
Glucocorticoid

deficiency,

which

may

be

observed

adrenalectomy, increases circulating levels of vasopressin(41).

following

chronic

However, this effect

seems to be mediated at the level of transcription of the vasopressin gene and not an
immediate release(41).

Therefore, in the animals in which the adrenal glands were

removed acutely, as in the present study, increased resting levels of vasopressin were
most likely due to anesthesia and surgical stress.
The large and sustained changes in resting hemodynamic variables following
AT1 angiotensinergic and ganglionic blockades required compensation with iv infusions
of phenylephrine to make the relative responses comparable across the experimental
groups.

It was extremely difficult to return both MAP and IVC to the pre-blockade

levels.

Since we tried to compensate most accurately for IVC, the resting MAP,

preceding the microinjections into the NTS in the groups where ganglionic blockade was
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combined with V1 vasopressinergic and with AT1 angiotensinergic blockades (Protocols
4 and 5), was slightly lower in comparison to other experimental groups. The long
lasting compensatory infusions of phenylephrine in Protocols 2-5 could facilitate central
baroreflex mechanisms(38). Therefore, the inhibition of enhanced baroreflex activity via
stimulation of NTS A1 adenosine receptors could result in relatively greater pressor and
vasoconstrictor responses compared to those observed in intact animals and following
V1 vasopressinergic blockade alone (Protocol 1) and V1 vasopressinergic blockade
combined with lumbar sympathectomy (Protocol 6). In fact, pressor and vasoconstrictor
responses tended to increase following AT1 receptor blockade although this tendency
did not reach statistical significance.

The pressor and vasoconstrictor responses

observed after adrenalectomy combined with ganglionic blockade (Protocol 3) were not
different from those observed following adrenalectomy alone in our previous study(47).
Finally, these responses (even if slightly exaggerated) were virtually abolished by the
vasopressinergic blockade (Protocols 4 and 5). Therefore, the potential central effects
of infusions of phenylephrine on responses to stimulation of NTS A1 adenosine
receptors were likely negligible and did not affect the primary conclusions of the present
study. The infused phenylephrine activated D1 adrenergic receptors located on vascular
smooth muscles, including those in the iliac vascular bed.

The occupation of D1

adrenergic receptors by an exogenous agonist could mask the effect of circulating
endogenous norepinephrine which may be potentially increased following stimulation of
NTS A1 adenosine receptors.

The peripheral interactions between simultaneously

activated V1, D1 and AT1 receptors could further complicate the comparison of relative
roles of humoral vasoconstrictor factors obscuring the smaller ones. Nevertheless, the
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marked effects of vasopressin V1 receptor blockade were evident in experimental
groups with and without phenylephrine compensation (Protocols 1 and 6 vs. Protocols 4
and 5). This indicates that vasopressin contribution to the iliac vasoconstriction was
much larger than the contribution (if any) of other potential vasoconstrictors
(norepinephrine and/or angiotensin II).
Conclusion
Selective stimulation of NTS A1 adenosine receptors triggers the release of
vasopressin into the circulation, strongly suggesting that A1 adenosine receptors are
likely located on afferent terminals and/or NTS interneurons mediating baroreflex control
of vasopressin release.

Vasopressin is a major humoral vasoconstrictor factor

contributing to the iliac vascular responses. The natural variability of MAP and IVC
responses to stimulation of NTS A1 adenosine receptors observed in intact animals is a
result

of

the

simultaneous

triggering

of

sympathetic

and

vasopressinergic

vasoconstriction counteracted by E-adrenergic vasodilation resulting mainly via
epinephrine release in response to the large increase in adrenal pre-ganglionic
sympathetic activity.
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CHAPTER 2
Activation of NTS A1 adenosine receptors provides differential neural and
humoral control of regional vascular beds
ABSTRACT
Our previous studies showed that stimulation of adenosine A1 receptors located
in the nucleus of the solitary tract (NTS) exerts counteracting effects on the iliac
vascular bed: activation of the adrenal medulla and ȕ-adrenergic vasodilation versus
sympathetic and vasopressinergic vasoconstriction. Since NTS A1 adenosine receptors
inhibit baroreflex transmission in the NTS and contribute to the pressor component of
the hypothalamic defense response, we hypothesized that these receptors also
contribute to the redistribution of blood from the visceral to the muscle vasculature via
prevailing sympathetic and vasopressinergic vasoconstriction in the visceral (renal and
mesenteric) vascular beds and prevailing E-adrenergic vasodilation in the somatic (iliac)
vasculature. To test this hypothesis we compared the A1 adenosine-receptor-mediated
effects of each vasoactive factor triggered by NTS A1 adenosine receptor stimulation
(N6-cyclopentyladenosine, CPA, 330 pmol in 50 nl) on the regional vascular responses
in urethane/chloralose anesthetized rats. The single factor effects were separated using
adrenalectomy, E-adrenergic blockade, V1 vasopressinergic blockade and sinoaortic
denervation.

In intact animals initial vasodilation was followed by large, sustained

vasoconstriction with smaller responses observed in renal vs. mesenteric and iliac
vascular beds. The initial E-adrenergic vasodilation prevailed in the iliac vs. mesenteric
and renal vasculature. The large and sustained vasopressinergic vasoconstriction was
similar in all vascular beds. Small sympathetic vasoconstriction was observed only in
the iliac vasculature in this setting. We conclude that although A1 adenosine-receptor-
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mediated E-adrenergic vasodilation may contribute to the redistribution of blood from the
visceral to the muscle vasculature, this effect is overridden by sympathetic and
vasopressinergic vasoconstriction.
INTRODUCTION
Recent studies have firmly established that adenosine operating as a
neuromodulator in the nucleus of the solitary tract (NTS) modifies cardiovascular control
(30; 37; 47; 48; 71; 77; 78; 80-82)

.

The NTS is a major integrative center for visceral and

autonomic reflexes and contains the greatest density of adenosine uptake sites within
the central nervous system

(11)

. Adenosine operates in the NTS in both physiological

and pathological situations. Under normal, physiological conditions a natural source of
adenosine is ATP released from neurons and glial cells(13). This occurs, for example
during the stress or hypothalamic defense response(80-82).

Extracellular ATP is

catabolized via ectonucleotidases to adenosine which acts globally on pre or postsynaptic A1 or A2a adenosine receptors located in the NTS(13;

94)

. Adenosine is also

released under pathological conditions such as ischemia, hypoxia and severe
hemorrhage via the breakdown of intracellular ATP(56; 89; 92). Therefore, adenosine is an
important neuromodulator helping to regain homeostasis in these life threatening
situations via specific modulation of central mechanisms of cardiovascular control.
Although adenosine is released globally, it may however, differentially modulate
autonomic reflexes integrated in the NTS(37;

71)

. The differential action of adenosine is

most likely due to differential localization of adenosine receptor subtypes on NTS
terminals/interneurons involved in different reflexes which finally target different
sympathetic outputs and vascular beds as we suggested previously(72; 77).
Adenosine may either inhibit or facilitate neurotransmission via A1 or A2a
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receptors, respectively. Selective stimulation of A1 versus A2a receptors often, but not
always, exerts counteracting hemodynamic effects.

Stimulation of A1 adenosine

receptors in the NTS yields predominately pressor and vasoconstrictor effects in the
hindlimb

accompanied

with

differential

regional

sympathoactivation

(adrenal>renallumbar)(76). In contrast, NTS A2a adenosine receptor stimulation yields
depressor responses, decreases in renal sympathetic nerve activity (RSNA), no
changes in lumbar sympathetic nerve activity (LSNA) and activation of pre-ganglionic
adrenal sympathetic nerve activity (pre-ASNA)(73;

74)

.

Interestingly, both receptor

subtypes preferentially activate the adrenal medulla. We have previously shown that
both A1 and A2a adenosine receptors evoke E-adrenergic vasodilation in the iliac
vascular bed, as E-adrenergic receptors are predominantly located in the skeletal
muscle vasculature(90). However, stimulation of A1 adenosine receptors alone in the
NTS often yields variable responses, although predominantly pressor and iliac
vasoconstrictor responses prevail(76). Recent studies have attributed this variability to
the activation of the adrenal medulla, the subsequent release of epinephrine eliciting
activation of E-adrenergic vasodilation which is simultaneously opposed by sympathetic
and vasopressinergic vasoconstriction(47;

48)

. The increased vasoconstrictor drive and

simultaneously triggered E-adrenergic vasodilation were most likely mediated via
inhibition of NTS baroreflex mechanisms(68; 71; 76).
Stimulation of NTS A1 adenosine receptors differentially affects baroreflex control
and baseline levels of regional sympathetic outputs, and baroreflex control of vascular
beds is regionally different(25;

64; 71)

.

Furthermore, there is differential regional

distribution of D1 and E2-adrenergic receptors(36;

90)

as well as differential reactivity of
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regional vascular beds to vasopressin and D1-adrenergic activation(28;

29; 34; 45)

.

Therefore it was likely that the contribution of vasoconstrictor and vasodilatory effects
may be different between somatic (iliac) vs. visceral vascular beds (mesenteric and
renal). In support of this hypothesis it has been shown that adenosine, operating mostly
via A1 receptors located in the NTS and rostral ventrolateral medulla, participates in the
pressor component of the hypothalamic defense response(80-82) and may possibly
contribute to the redistribution of blood flow from the viscera to skeletal muscle which is
a key element of this response(93). We hypothesized that NTS A1 adenosine receptor
induced sympathetic and vasopressinergic vasoconstriction would prevail over Eadrenergic vasodilation to a greater extent in the visceral vascular beds compared to
muscle. To address this hypothesis we compared the simultaneously recorded vascular
responses of iliac, mesenteric and renal vascular beds evoked by selective activation of
NTS A1 adenosine receptors in intact animals and after selective elimination of each
major vasodilating and vasoconstricting factor.
MATERIALS AND METHODS
All protocols and surgical procedures employed in this study were reviewed and
approved by the institutional Animal Care and Use Committee and were performed in
accordance with the Guiding Principles in the Care and Use of Animals endorsed by the
American Physiological Society and published by the National Institutes of Health.
Design
The relative contribution of three neural and humoral vasoactive factors
(sympathetic

and

vasopressinergic

vasoconstriction

opposed

by

E-adrenergic

vasodilation) to the regional vascular responses evoked by selective stimulation of NTS
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A1 adenosine receptors were studied in 53 male Sprague Dawley rats. The relative
changes in iliac (IVC), mesenteric (MVC) and renal (RVC) vascular conductance
evoked by microinjections into the NTS by the selective A1 adenosine receptor agonist
N6-cyclopentyladenosine (CPA, Tocris) observed in intact animals (n=8) were compared
with the responses evoked after the following six experimental procedures:
Protocol 1, bilateral adrenalectomy (ADX, n=8)
Protocol 2, blockade of E-adrenergic receptors (EX, n=7)
Protocol 3, selective vasopressin V1 receptor blockade (VX, n=7)
Protocol 4, sinoaortic denervation (SAD, n=7)
Protocol 5, bilateral adrenalectomy combined with selective vasopressin V1 receptor
blockade (ADX+VX, n=8)
Protocol 6, sinoaortic denervation combined with bilateral adrenalectomy (SAD+ADX,
n=8).
Blockade of E-adrenergic receptors was performed as in our previous studies via
injection of propranolol (2 mg/kg i.v.)(42;

47)

Vasopressin V1 receptors, mediating

vascular

by

i.v.

constriction,

were

blocked

.

injections

cyclopentylmethylenepropionyl,1-O-Me-Tyr,2Arg8]-Vasopressin,

of

[ȕ-Mercapto-ȕ,ȕselective

V1

antagonist, (20 ȝg/kg, Sigma) in doses which completely blocked vasoconstriction
evoked by i.v. injection of vasopressin (50 mU/kg, Sigma). The blockades were applied
~10 min before the microinjection into the NTS(47;

48)

.

Sinoaortic denervation was

accomplished at the beginning of surgery, as described previously(69;

76)

.

The

completeness of the denervation was tested ~2 hr later before the start of the protocol.
The procedure was considered complete if intravenous phenylephrine-induced
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increases in MAP > 30 mmHg did not decrease HR more than 5 beats/min.
Instrumentation and measurements
All procedures were described in detail previously(7; 42; 47; 48; 68; 74-76). Briefly, male
Sprague-Dawley rats (350-400 g, Charles River) were anesthetized with a mixture of Įchloralose (80 mg/kg) and urethane (500 mg/kg) i.p., tracheotomized, connected to a
small animal respirator (SAR-830, CWE, Ardmore, PA) and artificially ventilated with
40% oxygen 60% nitrogen mixture. Catheterizations of the right femoral artery and vein
were performed to monitor arterial blood pressure and infuse drugs. Arterial blood
gases were tested occasionally for appropriate experimental values (Radiometer,
ABL500, OSM3). Averaged values measured at the end of each experiment were the
following: pH =7.37±0.01, Po2 =144.2±5.0 mmHg, and Pco2 = 36.2±0.9 mmHg.
From a mid-abdominal incision, the left iliac artery, superior mesenteric artery
and the left renal artery were exposed. Pulsed Doppler blood flow velocity transducers
(Baylor Electronics) were placed around the arteries and connected to the flowmeter.
From the same mid-abdominal incision, in some animals, bilateral adrenalectomy was
performed.
Arterial blood pressure and iliac, mesenteric and renal and flow signals were
digitized and recorded with an analog-digital converter (Modular Instruments) interfaced
to a laboratory computer. The signals were recorded continuously using Biowindows
software (Modular Instruments), averaged over 5 second intervals and stored on hard
disk for subsequent analysis.
Microinjections into the NTS
After the exposure of the brainstem via dissection of the atlantooccipial the
animals were allowed to stabilize for at least 30 minutes before microinjections.
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Unilateral microinjections of CPA (330 pmol in 50 nl of artificial cerebrospinal fluid, ACF)
were made through multibarrel glass micropipettes into the medial region of the caudal
subpostremal NTS as described previously(7; 68; 74-76). This dose of CPA produced most
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Figure 11. Microinjection sites in the caudal subpostremal NTS for all experiments. Schematic
diagrams of transverse sections of the medulla oblongata from a rat brain. NTS, nucleus tractus
solitarii; AP, area postrema; c, central canal; 10, dorsal motor nucleus of the vagus nerve; 12,
nucleus of the hypoglossal nerve; Ts, tractus solitarius; Gr, gracile nucleus; Cu, cuneate
nucleus. Scale is shown at the bottom; the number on the left side of the schematic diagram
denotes the rostro-caudal position in millimeters of the section relative to the obex according to
the atlas of the rat subpostremal NTS by Barraco et al. (3). Microinjection sites were marked
with fluorescent dye and are denoted with the following symbols A: microinjections of CPA in
intact animals (ʀ), after bilateral adrenalectomy (U), and following ȕ-adrenergic blockade (ɿ).
B: microinjections of CPA after V1 vasopressin receptor blockade (Ƒ), following bilateral
sinoaortic denervation (), after combined adrenalectomy and V1 vasopressinergic blockade (Ŷ)
and following combined sinoaortic denervation and adrenalectomy ().

consistent, predominantly pressor responses in our previous study(76). The CPA was
dissolved in ACF and the pH adjusted to 7.2. In several previous studies we have
shown that microinjections of the same amount of vehicle (ACF) into the same site of
the NTS did not markedly affect MAP, HR, RSNA, LSNA and pre-ganglionic adrenal
sympathetic nerve activity (pre-ASNA) and regional vascular blood flows(7;

67; 71; 73-76)

.

The changes in all these variables were either not different from zero or smaller than
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natural, random fluctuations of these variables over the time of measurements. To
avoid the effect of desensitization of A1 adenosine receptors, in all experiments only one
dose of the agonist was microinjected into left or right side of the NTS.

All

microinjection sites were verified histologically (Figure 11).
Experimental protocols
Comparing regional vascular responses obtained in intact vs. specific
experimental conditions, we evaluated the specific contribution of three major
vasoactive factors (E-adrenergic vasodilation vs. sympathetic and vasopressinergic
vasoconstriction) to the responses of somatic (iliac) vs. visceral (mesenteric and renal)
vascular beds evoked by selective activation of A1 adenosine receptors in the NTS. Our
previous studies showed that only these three vasoactive factors significantly
contributed to iliac vascular responses evoked by stimulation of NTS A1 adenosine
receptors.
Basic experimental protocols allowed for comparisons of how elimination of one
vasoactive factor affects the responses observed in intact animals. However, selective
denervation of each vascular bed, which would allow for selective removal of the
sympathetic component of the responses, was extremely difficult and in a few
successful experiments arterial pressure was markedly lower than in other experimental
groups (<70 mmHg).

Therefore we evaluated the contribution of sympathetic

vasoconstriction alone to the regional vascular responses indirectly by removing the
adrenal and vasopressinergic components of the responses via adrenalectomy
combined with systemic V1 vasopressinergic blockade (Protocol 5). Adrenalectomy and
E-adrenergic blockade (Protocols 1 and 2, respectively) removed E-adrenergic
vasodilation; therefore, these protocols showed how sympathetic and vasopressinergic
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vasoconstriction triggered by activation of NTS A1 adenosine receptors affected regional
vascular beds. Blockade of V1 vasopressinergic receptors (Protocol 3) removed the
vascular action of vasopressin; therefore, showed how regional vascular beds respond
to E-adrenergic vasodilation opposed by sympathetic vasoconstriction. The contribution
of the vasopressinergic component alone to the regional vascular responses was
evaluated by subtracting sympathetic vasoconstriction (evaluated in Protocol 5) from
combined vasopressinergic and sympathetic vasoconstriction (Protocol 1).

The

contribution of E-adrenergic vasodilation alone to the regional vascular beds responses
was evaluated by subtracting sympathetic vasoconstriction (Protocol 5) from combined
sympathetic neural and adrenergic responses (evaluated in Protocol 3). To evaluate
separate effects of each humoral factor we subtracted the sympathetic component of
the responses (averaged values obtained in Protocol 5) from each single animal
response in Protocols 1 and 3 and then averaged the data in each experimental group.
In addition, sinoaortic denervation (Protocol 4), which removed baroreflex
vasopressinergic and sympathetic vasoconstriction and the baroreflex dependent part of
the activation of the adrenal medulla, evaluated the relative regional vasodilation
mediated via the non-baroreflex component of the activation of the adrenal medulla(76).
Finally, sinoaortic denervation combined with bilateral adrenalectomy removed all three
major vasoactive factors triggered by NTS A1 adenosine receptor stimulation. This
protocol tested if the three vasoactive factors (sympathetic and vasopressinergic
vasoconstriction opposed by E-adrenergic vasodilation), known to affect the somatic
(iliac) vascular bed(47;

48)

, are the only major factors affecting visceral vascular beds

(mesenteric and/or renal) in response to stimulation of NTS A1 adenosine receptors.
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Data Analysis
The regional vascular conductance was calculated similarly as in our previous
studies by dividing the regional blood flows, expressed as Doppler shift (in Hz), by MAP
(in mmHg)(47; 48). The absolute values of vascular conductance depend to some extent
on positioning of the probe around the arteries; therefore comparisons between the
relative changes were more reliable. In all experimental groups the hemodynamic data
were averaged in 1 min intervals over a 20 min period of the response. Since the
responses were biphasic: initial decrease in MAP and vasodilation (~ first 5 min of the
response) followed by the pressor and vasoconstrictor phase of the response (last ~15
min). In addition we calculated the overall responses for each vascular bed calculating
the integral of the response for first 5 min of the responses, where vasodilation
prevailed, and the last 15 min of the responses, where vasoconstriction prevailed. To
make the integral values comparable between the phases of the responses we
normalized the integral values to one minute by dividing the total integral for the first and
second phase of the response by 5 and 15, respectively.
Two way ANOVA was used to evaluate the relative contribution of the three
vasoactive factors (sympathetic and vasopressinergic vasoconstriction opposed by Eadrenergic vasodilation) to the responses of the three vascular beds (iliac, mesenteric
and renal) in respect to the integral responses. Two way ANOVA was also used for
comparing the dynamics of the response in each vascular bed observed under each
experimental condition, and for each single vasoactive factor (20 time points of the
responses vs. 3 vascular beds). A t-test with Bonferroni adjustments was used for the
calculation of specific differences between the groups for those comparisons where
interactions of the vasoactive factors or the time vs. the vascular beds were significant.
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RESULTS
Resting values of MAP, HR, iliac, mesenteric and renal blood flow and
conductance for each experimental group, measured just before stimulation of NTS A1
Table 6. Resting values of hemodynamic parameters in each experimental group.
Experimental
n
procedure

Mean
Arterial
Pressure,
mmHg

Heart Rate,
beats/min

Blood Flow, Hz

Vascular Conductance, Hz/mmHg

Iliac

Mesenteric

Renal

Iliac

Mesenteric

Renal

INTACT

8

91.4±4.0

323.5±9.4

826.6±63.1†‡

1228.4±72.3

1771.9±213.7

9.3±1.0†‡

13.7±1.2

19.3±2.2

ADX

8

82.3±1.8

336.1±16.3

834.4±68.7†‡

1344.0±169.7•

2283.6±215.2

10.3±0.9†‡

16.4±2.0•

27.8±2.5*

ßX

7

92.1±3.8

300.0±7.5

697.0±71.3‡

1424.8±138.8

1761.4±307.3

7.6±0.7‡

15.5±1.3

19.3±3.6

VX

7

81.2±2.6

351.7±22.3

997.0±194.4‡

1184.6±129.8•

2685.2±123.5*

12.5±2.6‡

14.6±1.5•

33.1±1.3*

SAD

7

86.1±5.7

386.7±16.3*

732.4±86.8‡

1150.7±163.7

1609.9±200.2

8.7±1.2†‡

13.6±1.9

18.7±2.1

ADX+VX

8

76.5±2.7*

341.8±10.1

1554.6±149.1*

1384.8±154.4

1550.9±153.3

20.6±2.2*

18.6±2.4

20.3±1.9

SAD+ADX

8

78.8±2.3*

414.4±21.9*

1076.3±192.2‡

969.1±71.7*•

2115.6±231.5

13.7±2.4‡

12.4±1.0•

27.1±3.2

Data are means ±SE; n=number of rats. Resting values for intact (INT) animals and following: bilateral
adrenalectomy (ADX), ȕ-adrenergic blockade (ȕX), vasopressin V1 receptor blockade (VX), adrenalectomy +V1
receptor blockade (ADX+VX), sinoaortic denervation (SAD) and sinaortic denervation + adrenalectomy (SAD+ADX).
*P<0.05 VS INTACT. P<0.05: † Iliac vs. mesenteric, ‡ Iliac vs. renal, • Mesenteric vs. renal.

adenosine receptors, are presented in Table 6. In most cases vascular conductance
observed in specific beds in all experimental groups was not different from that
observed in intact animals; the only exemptions were the increase in iliac vascular
conductance following bilateral adrenalectomy combined with V1 vasopressinergic
blockade and a smaller increase in renal conductance following V1 adrenalectomy alone
and vasopressinergic blockade alone.

Therefore changes in the relative vascular

responses evoked by activation of NTS A1 adenosine receptors were comparable
across the experimental groups with only small limitations. HR was significantly higher
in the two groups where sinoaortic denervation was performed, as expected. MAP was
lower compared to intact animals only in two experimental groups: following bilateral
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adrenalectomy combined with V1 vasopressinergic blockade or adrenalectomy
combined with sinoaortic denervation.
The maximal effects evoked by E-adrenergic and V1 vasopressinergic blockades
in the regional vascular beds and MAP are presented in Table 7.

Note that iliac

vasoconstriction in response to E-adrenergic blockade was approximately twice as large
Table 7. Average maximum hemodynamic responses evoked by E-adrenergic and V1 vasopressinergic blockades.
Experimental
procedure

n

¨%MAP

¨%HR

EX
VX
ADX + VX

7
8
8

19.2±4.0
-16.6±4.7
-30.6±5.2

-8.6±1.6
6.1±4.0
12.9±5.0

¨% Iliac

¨% Mesenteric

¨% Renal

Vascular Conductance
-30.3±4.2†‡
38.4±9.9
55.6±11.7†‡

-16.2±4.0
26.7±6.3
38.4±7.4

-13.0±3.3
25.9±7.4
27.9±8.6

Data are means r SE; n = number of rats. Beta adrenergic blockade (EX), Vasopressin V1 receptor blockade (VX). P<0.05:† Iliac
vs. mesenteric, ‡ Iliac vs. renal. No significant differences between mesenteric vs. renal vascular beds were observed.

as that observed in the mesenteric and renal vascular beds. This suggests larger tonic
E-adrenergic vasodilation in the iliac vs. both visceral vascular beds. In contrast, no
significant differences between the regional vascular beds were observed in response
to V1 vasopressinergic blockade.
Comparison of hemodynamic responses observed in intact vs. experimental groups
Figure 12 presents comparisons of averaged responses evoked by selective
stimulation of NTS A1 adenosine receptors in intact animals and following specific
experimental procedures. Two way ANOVA showed significant differences between all
experimental vs. intact conditions except for MVC in adrenalectomized animals and
RVC following combined adrenalectomy plus vasopressinergic blockade, which did not
reach statistical significance (P=0.195 and P=0112, respectively) (Figure 12). In intact
animals the typical variability of the responses to stimulation of NTS A1 adenosine
receptors was observed, similar as that reported in previous studies from our
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laboratory(47; 48; 76). In the initial phase of the responses (approximately first 5 minutes)
depressor and vasodilatory responses prevailed. In the subsequent 15 minutes (or
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Figure 12. Mean arterial pressure (MAP), iliac (IVC), mesenteric (MVC) and renal (RVC) vascular
conductance responses to microinjection of adenosine A1 receptor agonist (CPA, 330 pmol/50 nl) into the
subpostremal NTS in intact rats (-ż-, open circles) compared to the responses evoked following different
experimental procedures (-Ɣ-, filled circles). Data are means ± SE. *P<0.05 vs. intact animals.
Abbreviations: bilateral adrenalectomy (ADX), ȕ-adrenergic blockade (ȕX), vasopressin V1 receptor
blockade (VX), bilateral sinoaortic denervation (SAD), bilateral adrenalectomy + vasopressin V1 receptor
blockade (ADX+VX) and bilateral sinoaortic denervation + bilateral adrenalectomy (SAD+ADX).

more) of the responses pressor and vasoconstrictor responses prevailed. Overall, the
increases in mean arterial pressure (MAP) and vasoconstriction in all vascular beds
dominated over 20 minutes of the responses in the intact group. Adrenalectomy and Eadrenergic

blockade

eliminated

initial

vasodilation

thus

sympathetic

and
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vasopressinergic vasoconstriction dominated in these groups.

Blockade of V1

vasopressinergic receptors virtually eliminated the vasoconstrictor component of the
responses; adrenergic vasodilation prevailed over sympathetic vasoconstriction in this
setting in all vascular beds.

Sinoaortic denervation eliminated reflex sympathetic

vasoconstriction and vasopressin release(48; 76).

In this situation non-baroreflex

activation of the adrenal medulla(76) was smaller than the activation mediated via
combined baro- and non-baroreflex mechanisms; however, in this setting the
vasodilatory factor was not opposed by any vasoconstricting factors (sympathetic
nerves and vasopressin). Therefore, vasodilation observed in this group did not differ
substantially compared to that observed after blockade of V1 vasopressin receptors
alone. Combined adrenalectomy and V1 vasopressinergic blockade eliminated both
major humoral factors, revealing that the contribution of sympathetic vasoconstriction to
the responses was very small, especially in the mesenteric and renal vascular beds.
Finally, combined sinoaortic denervation and bilateral adrenalectomy eliminated all
three primary vasoactive factors triggered by stimulation of NTS A1 adenosine
receptors and these residual responses were not different from those where only
sympathetic nerves were active. Since in most of the experimental groups more than
one vasoactive factor was at play, the relative comparisons of the effect of the
vasoactive factors on regional vascular beds was rather complex, especially that these
factors may differentially interact with each other in a specific vascular bed. To simplify
the picture we further compared regional vascular responses due to the separate effects
of sympathetic nerves, vasopressin and epinephrine; these single factor effects were
calculated from basic experimental groups as described in the experimental protocols
section.
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Figure 13. Comparison of regional hemodynamic responses (iliac, mesenteric and renal) mediated via
three major vasoactive factors (sympathetic nerves, vasopressin and epinephrine) triggered by selective
stimulation of A1 adenosine receptors located in the NTS (microinjections of CPA, 330 pmol/50 nl). Data
are means ± SE. *, P<0.05 renal vs. iliac and mesenteric vascular beds. Abbreviations as in Figure 2.
Single factor effects were calculated from basic experimental groups: sympathetic nerve effect (ADX+VX),
vasopressin ((ADX-(ADX+VX)), epinephrine ((VX-(ADX+VX)), and epinephrine released via non-baroreflex
mechanism following sinoaortic denervation (SAD). These effects are compared to combined effect of all
vasoactive factors operating in intact animals and after elimination of all major vasoactive factors in
S

Differential regional vascular responses to single vasoactive factors triggered by
stimulation of NTS A1 adenosine receptors
Figure 13 compares the averaged responses of three vascular beds (iliac vs.
mesenteric vs. renal) mediated via the three major vasoactive factors (sympathetic
nerves, vasopressin and epinephrine) activated by the selective stimulation of A1
adenosine receptors located in the NTS. The impact of each factor on each vascular
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bed was compared with the combined impact of all these factors in intact animals and
with a "negative control" group where activation of all these factors was prevented via
combined bilateral sinoaortic denervation and adrenalectomy (SAD+ADX). Two way
ANOVA did not show significant differences between time-courses of regional vascular
responses evoked by each vasoactive factor alone (P>0.05 for vascular bed x time
interactions). Nevertheless, all these factors acting together in intact animals revealed
significantly smaller vasoconstriction in renal vs. both the iliac and mesenteric vascular
beds, especially so in the later phase of the responses (P=0.024 for vascular beds x
time interaction) (Figure 13, first upper panel). The lack of differences between timecourses of whole vascular responses to single vasoactive factors were not surprising
taking into consideration the biphasic dynamics of the responses: E-adrenergic
vasodilation prevailed in first 5 min of the responses whereas neural and
vasopressinergic vasoconstriction prevailed in the remaining portion of responses. The
differences between regional vascular responses became significant when both phases
of the responses were analyzed separately as an integral of the first 5 minutes (mostly
vasodilation) and the last 15 minutes (mostly vasoconstriction) of the responses (Figure
14 A and B). In the initial phase of the responses (first 5 minutes) two way ANOVA
showed significant vascular bed vs. experimental condition interaction (P=0.026),
whereas in the later phase the regional vascular responses were more uniform (P=
0.441 and P= 0.205 for vascular beds and vascular bed x experimental conditions
interaction, respectively).
Interestingly, in the initial phase of the responses virtually no neural
vasoconstriction was observed; the mesenteric vascular bed even tended to dilate
(P=0.114 vs. zero).

In the later phase of the response iliac vasoconstriction was
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significant (P=0.010 vs. zero) whereas renal and mesenteric vasoconstrictions remained
very small and not different from zero. Vasopressin initially evoked relatively small
responses with significantly greater vasoconstriction in the mesenteric vs. the iliac and
renal vascular beds (Figure 14A); however, in the later phase of the responses
vasopressinergic vasoconstriction increased systematically and large, sustained
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Figure 14. Integral hemodynamic responses (iliac, mesenteric and renal) evoked by selective stimulation
of A1 adenosine receptors located in the NTS. Data were calculated from traces presented in Figure 3.
Panel A, integrals measured over the first 5 min of the responses, when decreases in MAP and
vasodilation prevailed. Panel B, integrals measured over the last 15 min of the responses, when increases
in MAP and vasoconstriction prevailed. Data are means ± SE. *, P<0.05 between vascular beds linked
with the horizontal lines #P<0 05 vs zero Abbreviations as in Figure 2

vasoconstriction with no differences between the vascular beds was observed (Figure
13, left upper panel). In the initial phase of the responses iliac E-adrenergic vasodilation
was significantly greater than that observed in the mesenteric vascular bed (P=0.020)
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and tended to be greater than that observed in the renal vasculature (P=0.113) (Figure
14A). In the later phase of the responses these regional differences persisted to some
degree (Figure 14B). The regional effects of epinephrine released via non-baroreflex
mechanisms (in sinoaortic denervated animals) were similar to those observed when
the adrenal medulla was activated by both baro- and non-baroreflex mechanisms
(Figures 13 and 14 A and B). Finally, the elimination of all three vasoactive factors by
means of combined bilateral sinoaortic denervation and adrenalectomy virtually
abolished the responses in all vascular beds.
DISCUSSION
Activation of A1 adenosine receptors in the NTS contributes to cardiovascular
component of the hypothalamic defense response (HDR); specifically, it contributes to
the inhibition of baroreflex transmission in the NTS and to the pressor component of
HDR(71;

76; 80-82)

. The present study tested the hypothesis that activation of NTS A1

adenosine receptors may also contribute to the crucial component of HDR which is the
redistribution of blood from the viscera to the muscle(93). Therefore in the present study
for the first time regional vascular responses evoked by selective stimulation of NTS A1
adenosine receptors were compared. Furthermore, we investigated the mechanisms
mediating the complex hemodynamic responses and their regional variability.

The

major finding of the present study is that three major vasoactive factors naturally
triggered in response to the stimulation, i.e. sympathetic and vasopressinergic
vasoconstriction counteracted by E-adrenergic vasodilation(47; 48), had differential effects
on somatic (iliac) vs. visceral (mesenteric and renal) vasculatures.

Sympathetic

vasoconstriction was observed in the iliac vasculature only. The greatest vasodilation
mediated via released epinephrine and E-adrenergic mechanism was observed in the
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iliac compared to the two other vascular beds.

The released vasopressin initially

evoked small preferential mesenteric vasoconstriction, and then large, steady
vasoconstriction, which was similar in all vascular beds. Taken together these results
suggest that A1 adenosine receptors operating in the NTS may contribute to the
redistribution of blood from the visceral to the somatic (muscle) vasculature via
preferential iliac vasodilation; however, two vasoconstricting factors simultaneously
triggered by the stimulation diminished this effect by limiting skeletal muscle
vasodilation.

When

all

vascular

factors

act

simultaneously

(intact

group)

vasoconstriction prevailed in the iliac and mesenteric vs. the renal vascular bed. These
data combined with previous studies from our laboratory and by others show that
although the A1 adenosine receptors located in the NTS contribute to the pressor
component of the stress/hypothalamic defense response, the activation of these
receptors may have a small if any effect on the redistribution of blood from the visceral
to the muscle vasculature(71; 76; 80-82).
NTS adenosine receptors and differential control of regional vascular beds by neural
and humoral factors: Sympathetic nerves
It has been reported that stimulation of the superior laryngeal nerve, which
conducts also the aortic depressor nerve fibers in rats, evokes much greater iliac than
renal and mesenteric vasodilation(25). Also stimulation of the aortic depressor nerve
evoked preferential iliac vasodilation in rats(64). The activation of D1 adrenergic receptors
(a major mechanism mediating sympathetic baroreflex responses) with metoxamine in
mongrel dogs led to a greater vasoconstriction in iliac compared to renal and
mesenteric vascular beds(34). Similarly, iliac capacity for baroreflex vasoconstriction and
vasodilation in greyhounds was greater in iliac than mesenteric an renal vascular
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beds(18). These reports suggested that baroreflex sympathetic responses may be
greater in iliac than in renal and mesenteric vascular beds. Therefore we expected that
A1 adenosine receptor mediated inhibition of NTS baroreflex mechanisms(71;

76)

will

result in a greater sympathetic iliac vasoconstriction compared to that observed in
mesenteric and renal vascular beds.

The present study generally confirmed this

hypothesis. However, the lack of neural vasoconstrictor responses in renal and
mesenteric vascular beds was unexpected (Figure 14A and B).

The neural

vasoconstrictor component of the responses was relatively small in all vascular beds
compared to the relatively large effects evoked by the increases in circulating
epinephrine and vasopressin. No significant vasoconstriction was observed in first 5
min of the responses whereas in the later phase of the response (the last 15 min) only
iliac vasoconstriction was significantly different from zero as well as from both other
vascular beds, consistent with our previous reports(47; 48).
Interestingly, the mesenteric vascular bed tended to vasodilate and vasoconstrict
in the initial and the later phase of the response, respectively, although the differences
did not reach statistical significance vs. zero (P= 0.114 and P= 0.249, respectively).
This may suggest that in the early phase of the responses sympathetic vasoconstriction
was counteracted by neurogenic vasodilation and that this vasodilation weakened with
time. The most likely vasodilator factor responsible for this counteraction could be preabsorbed epinephrine released from sympathetic terminals, as suggested previously by
Berecek and Brody(10). The action of pre-absorbed epinephrine would decrease with
time over the response in adrenalectomized animals. Consistently sympathetic (D1adrenergic) vasoconstriction would increase with time as was observed. This is also
consistent with an initially smaller and then greater neural vasoconstriction in the iliac
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vascular bed (Figure 14 A and B).

Among other vasodilatory neurotransmitters

potentially released from sympathetic nerve terminals in the mesenteric and iliac
vasculature, for example, nitric oxide (NO), calcitonin gene related peptide (CGRP) and
adenosine as a catabolite of neuronally released ATP should be considered(13; 21; 43; 57).
Vasopressin
In the present study we found that vasopressin triggered by selective activation
of NTS A1 adenosine receptors initially constricts the mesenteric vascular bed to a
greater extent than the renal and iliac vasculature, whereas in the later phase of the
response no regional differences between vasopressinergic vasoconstriction were
observed. Our data are consistent with regional vascular responses observed following
i.v. infusion of exogenous vasopressin in rats where small doses of vasopressin evoked
preferential vasoconstriction in the mesenteric compared to the renal and iliac
vasculature, whereas with larger doses the regional differences diminished or
disappeared(28;

29)

. It should be mentioned that regional effects of vasopressin in rats

are different from those observed in dogs where vasopressinergic vasoconstriction
dominates in the iliac vasculature(34;

45)

. Most likely in the present study the initial

release of vasopressin was small and it increased with the time of the response
(Figures 13 and 14).

In our previous study we found that the level of circulating

vasopressin measured ~ 8 min after microinjection of A1 receptor agonist (CPA) into the
NTS increased 4-fold compared to the resting level. Note that in the present study
vasopressinergic vasoconstriction increased systematically up to ~ 8 min of the
response and then was maintained at this high, steady level throughout the observed
response (Figure 13 last upper panel). Circulating vasopressin is quickly catabolized at
normal body temperature(17); therefore, the large, sustained vasopressinergic
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vasoconstriction observed in the present study suggests that vasopressin was
continuously released into the circulation as long as the baroreflex mechanism was
inhibited by stimulation of A1 adenosine receptors, which can last over an hour at this
dose of A1 agonist (CPA, 330 pmol)(71).
In contrast to activation of NTS A1 adenosine receptors the activation of A2a
adenosine receptors do not affect vasopressin release as A2a receptors do not inhibit
baroreflex transmission in the NTS(37;

76)

.

In addition, previous studies from our

laboratory showed that preferential iliac vasodilation observed after selective activation
of NTS A2a adenosine receptors was completely abolished following bilateral
adrenalectomy and lumbar sympathectomy and no vasoconstrictor component of the
response persisted following these procedures(7; 42).
Epinephrine
The preferential iliac vs. mesenteric and renal vasodilation dominated in the initial
phase of the responses (Figures 13 and 14).

This vasodilation was mediated via

activation of the adrenal medulla, release of epinephrine and E-adrenergic vasodilation.
The initial vasodilation was abolished in all vascular beds after bilateral adrenalectomy
or E-adrenergic blockade (Figure 12).

The greatest E-adrenergic vasodilation was

observed in the iliac vascular bed, which supplies mostly skeletal muscles, compared to
the vasodilation of both visceral vascular beds.

This is consistent with preferential

expression of E-adrenergic receptors in the skeletal muscle vasculature(90) as well as
with the greater tonic E-adrenergic vasodilation in iliac compared to mesenteric and
renal vascular beds as observed in the present study (Table 7). The preferential iliac
vasodilation was observed in the group of animals where the whole epinephrine effect
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was calculated from basic experimental groups ((VX-(ADX+VX)) as well as in the group
where sinoaortic denervation was performed and non-baroreflex epinephrine effects
were directly measured (Figures 13 and 14). The consistent results obtained using the
two different experimental approaches attested that the arithmetical separation of single
vasoactive factors in the present study was accurate.
According to our previous reports sinoaortic denervation or blockade of
glutamatergic

transmission

in

sympathoexcitatory responses(76).

the

NTS

abolishes

pressor

and

regional

However, A1 receptor mediated activation of the

adrenal medulla is only attenuated but not abolished in this setting. Therefore, following
sinoaortic denervation the adrenal medulla was still activated by stimulation of NTS A1
adenosine receptors, although to a lesser extent than in intact animals where both baroand non-baroreflex components of the activation of the adrenal medulla were present.
In fact, in the present study regional vasodilatory responses evoked by combined baroand non-baroreflex mechanisms tended to be greater compared to those where only
non-baroreflex mechanism was active (Figure 14), although these differences did not
reach statistical significance.
Preferential E-adrenergic iliac vasodilation, triggered by selective stimulation of
NTS

A1

adenosine

receptors,

was

masked

by

simultaneous

neural

and

vasopressinergic vasoconstriction. However, combined activation of both A1 and A2a
adenosine receptor subtypes in the NTS may significantly contribute to the preferential
iliac vasodilation and to the redistribution of blood from visceral to somatic vascular
beds. Previous studies from our laboratory showed that selective stimulation of NTS
A2a adenosine receptors evoked much greater iliac vs. renal and mesenteric
vasodilation(7); the E-adrenergic vasodilation contributed to ~80% of this preferential
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iliac vasodilation(42).
Potential Mechanisms
The present study showed that selective activation of NTS A1 adenosine
receptors preferentially disinhibited vasopressin release and activated sympathetic
outputs to the adrenal medulla, whereas other sympathetic outputs were activated to a
much lesser extent.

What possible mechanism(s) may be responsible for this

difference? Our previous studies strongly suggested that A1 adenosine receptors act
mainly via inhibition of baroreflex transmission in the NTS(71;

76)

.

This inhibition is

responsible for all pressor and sympathoexcitatory responses including vasopressin
release(48). Since the vasopressinergic vasoconstriction observed in the present study
was several fold greater than the regional sympathetic vasoconstriction, it seems that A1
adenosine receptors may be located preferentially on those NTS baroreflex
terminals/interneurons which are responsible for the tonic baroreflex restraint of
vasopressin release and to a much lesser extent on NTS neurons responsible for tonic
baroreflex restraint of regional sympathetic outputs. In fact, the increases in lumbar and
renal sympathetic nerve activity, observed in a previous study from our laboratory(76),
were 2-3-fold smaller than that observed in the adrenal nerve.
One other reason for much smaller neural than humoral vasoconstriction
observed in the present study may be the non-homogenous character of efferent
sympathetic fibers selectively activated/disinhibited by A1 adenosine receptors in the
NTS.

Efferent sympathetic terminals, in addition to the major neurotransmitter,

norepinephrine, may secrete also several vasodilatory neurotransmitters including NO,
CGRP, and ATP which after degradation to adenosine via ectonucleotidases may cause
vasodilation via both A1 and A2a adenosine receptor subtypes(13;

20; 21; 43; 57; 94)

.

A1
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adenosine receptors may disinhibit both vasoconstrictor and vasodilatory efferent fibers
and these effects may cancel each other.

The net effect may be relatively small

vasoconstriction (as observed in the iliac vasculature), no significant response (as
observed in renal vasculature) or even a tendency to vasodilation (as observed in the
mesenteric vascular bed).

In a previous study from our laboratory we observed a

similar phenomenon revealed by selective stimulation of NTS A2a adenosine receptors.
This stimulation triggered preferential iliac vasodilation, compared to the mesenteric and
renal vasculatures, whereas sympathetic activity directed to the iliac vascular bed did
not change in this setting(7; 73). Taken together these observations could suggest that
LSNA may not contribute to the response. However, although the total LSNA did not
alter, the lumbar sympathectomy did contribute to over 20% of the preferential iliac
vasodilation suggesting that both vasoconstricting and vasodilatory fibers (most likely
releasing NO) might have been simultaneously activated(21;

42; 57)

.

Which specific

neurotransmitters are released from these regional sympathetic nerves in response to
stimulation of NTS adenosine receptor subtypes awaits further investigation.
In absolute terms the regional E-adrenergic vasodilatory responses were much
greater than the sympathetic vasoconstrictor responses, as blockade of V1
vasopressinergic receptors reversed vasoconstriction (which dominated in intact
animals) into marked vasodilation in all three vascular beds (Figure 12). This indicated
that E-adrenergic vasodilation markedly prevailed over sympathetic vasoconstriction in
all vascular beds. It should be stressed that NTS A1 adenosine receptors activate the
adrenal medulla via both baroreflex and non-baroreflex mechanisms which is consistent
with the greater overall activation of ASNA compared to other sympathetic outputs(76).
The baroreflex component of this response was relatively weak (similarly as it was
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observed for baroreflex-mediated regional vasoconstriction discussed above) as there
were no significant differences between total vs. non-baroreflex E-adrenergic
vasoconstriction observed in each vascular bed in these two situations (Figure 14). The
non-baroreflex component of the activation of the adrenal medulla is most likely
mediated

via

descending

pathways

from

hypothalamic

nuclei

which

utilize

nonglutamatergic neurotransmitters as we proposed previously(77). However, specific
pathways and neurotransmitters responsible for non-baroreflex activation of the adrenal
medulla remain unknown. All the above hypotheses should be addressed in future
studies.
Limitations of the method
Anesthesia and recent surgical stress most likely elevated resting levels of
sympathetic activity, circulating epinephrine and vasopressin.

This could attenuate

further increases of these vasoactive factors due to stimulation of NTS A1 adenosine
receptors.

In fact, in our previous study, which was performed under similar

experimental conditions, the resting vasopressin levels were moderately elevated
compared with the levels measured in conscious animals(12; 32; 35; 48; 53; 54). Nevertheless,
the activation of NTS A1 adenosine receptors evoked large (over 4-fold) increase of
circulating vasopressin compared to the elevated baseline(48).

Also regional

sympathetic outputs, especially that directed to the adrenal medulla, were significantly
activated in response to stimulation of NTS A1 adenosine receptors(76). This attests that
despite of the increased resting levels of humoral and neural factors the stimulation of
NTS A1 receptors is potent to evoke marked responses in all these factors. In addition,
the potential effects of anesthesia and recent surgery presumably affected all vascular
beds similarly; therefore we believe that the relative regional differences in
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responsiveness to the vasoactive factors were preserved under these experimental
conditions.
In this and our previous study, MAP decreased following V1 vasopressinergic
blockade and was allowed to return spontaneously toward resting levels. We did not
compensate for the decrease of MAP with phenylephrine infusion to avoid potentially
different D1 adrenergic vasoconstriction of different vascular beds due to differential
regional expression of these receptors(34;

36)

; such a compensation could distort the

responses to the experimental factors. The baroreflex compensation of the depressor
response evoked by V1 vasopresinergic blockade probably elevated baseline
sympathetic activity which may have attenuated the sympathoactivation in response to
stimulation of NTS A1 adenosine receptors.

Therefore, the neural sympathetic

component of the responses could be underestimated in this study. Nevertheless, we
believe that regional differences in sympathetic responses were preserved, as
vasoconstriction in the iliac vascular bed significantly increased whereas the responses
of the mesenteric and renal vascular beds were not different from zero.
Adrenalectomy and E-adrenergic blockade most likely diminished cardiac output
regulatory

capacity.

Therefore,

following

combined

adrenalectomy

and

V1

vasopressinergic blockade (Protocol 5) MAP and IVC did not fully recover, whereas
following V1 vasopressinergic blockade alone (Protocol 3) full recovery of these
parameters was observed (Table 6).
Renal auto-regulation was most likely responsible for much smaller responses
evoked in this vascular bed in intact animals and under most of the experimental
conditions (Figure 14). Nevertheless, vasopressin had a relatively large effect on the
renal vasculature, not different from that observed in the iliac and mesenteric
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vasculature beds during the whole time-course of the responses (Figure 13).
Consistently, following V1 vasopressinergic blockade significantly increased renal
vascular conductance remained significantly elevated compared to that observed in
intact animals whereas MAP, IVC and MVC completely recovered following the
blockade (Table 6).
Although we used a standard method of recording regional vascular
conductance, which is well established in our laboratory, the relatively small neural vs.
humoral regional vascular responses could raise a question if sympathetic nerves were
potentially damaged during the procedure. This was rather unlikely, because electrical
stimulation of the aortic depressor nerve (8V, 0.1 ms, 8-64 Hz) and activation of
cardiopulmonary receptors with i.v. phenylbiguanide (1-8 Pg/kg) applied in some intact
animals evoked large sympathetic vasodilation in all vascular beds with patterns similar
to that described previously by Faber and Brody(25).
Conclusions
Three major vasoactive factors triggered by stimulation of NTS A1 adenosine
receptors in the NTS (sympathetic and vasopressinergic vasoconstriction opposed by Eadrenergic vasodilation) differentially affect regional vascular beds. The E-adrenergic
vasodilation, which dominates in the initial phase of the response, was significantly
greater in the iliac than the mesenteric and renal vasculatures. Significant sympathetic
vasoconstriction was observed in the iliac but not in the mesenteric and renal vascular
beds. In contrast, vasopressin exerted marked, sustained vasoconstriction similar in all
vascular beds, except for a small, initial preferential mesenteric vasoconstriction. This
pattern of regional vascular responses suggests that activation of A1 adenosine
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receptors in the NTS has minor, if any, effect on redistribution of blood from the visceral
to somatic (muscle) vasculature.
Perspectives
Previous studies from our laboratory and by others strongly suggested that
adenosine operating via A1 adenosine receptors in the NTS may contribute to the
pressor component of hypothalamic defense response, most likely via the inhibition of
baroreflex

transmission

in

the

NTS

which

disinhibits

efferent

sympathetic

vasoconstriction and vasopressin release(48; 71; 76; 80-82). Adenosine operating in the NTS
via both A1 and A2a receptor subtypes preferentially activates the adrenal medulla
leading to preferential iliac vasodilation(7;

42)

, which is the major mechanism mediating

increases in blood supply to skeletal muscles during stress/HDR in the rat(93). However,
the present study showed that although activation of NTS A1 adenosine receptors
preferentially increases iliac vascular conductance in the early phase of the response,
this effect is overridden by the powerful V1 vasopressinergic vasoconstriction in later
phase of the response, which diminished the contribution of NTS A1 adenosine
receptors to the redistribution of blood. To what extent do these potential mechanisms,
triggered by stimulation of NTS adenosine receptor subtypes, contribute to the pattern
of autonomic responses evoked by the stress or HDR requires further investigation.
Interestingly, some components of the autonomic responses evoked by selective
activation of adenosine receptor subtypes in the NTS remain inconsistent with the
pattern of HDR.

For example, the decreases in HR due to A1 and A2a adenosine

receptor stimulation, the depressor responses evoked by A2a receptor stimulation, and
the lack of contribution of NTS A2a receptors to the baroreflex inhibition are most likely
components of other autonomic mechanisms, not related to the HDR. Alternatively, the
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responses opposite to the HDR pattern may contribute to fine tuning of the HDR
autonomic pattern. Further studies are necessary to specify the autonomic mechanisms
to which these non-HDR effects mediated by NTS adenosine receptor subtypes may
contribute.
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NEURAL AND HUMORAL CONTROL OF REGIONAL VASCULAR BEDS VIA A1
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Previous studies from our laboratory showed that activation of NTS A1 adenosine
receptors yields variable hemodynamic responses with prevailing pressor and iliac
vasoconstrictor responses.

These responses are accompanied with differential

activation of regional sympathetic activity (adrenal>>renallumbar) and inhibition of
baroreflex mechanisms at the level of the NTS. The variability of the hemodynamic
responses was a result of simultaneous E-adrenergic vasodilation counteracted with
sympathetic and unknown humoral vasoconstriction.

Among many potential

vasoconstrictors vasopressin, angiotensin II and circulating norepinephrine were
considered.

Therefore, blood pressure and iliac vascular responses evoked by

selective stimulation of NTS A1 adenosine receptors (CPA 330 pmol/ 50 nl) in intact
anesthetized (urethane/chloralose) Sprague Dawley rats were compared with the
responses evoked following the blockade of each potential vasoconstrictor mechanism.
I found that vasopressin is the major vasoconstrictor released into the circulation most
likely as a result of A1-adenosine-receptor-mediated inhibition of baroreflex mechanism
and disinhibition of tonic restraint of vasopressin release. Angiotensin II and circulating
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norepinephrine had virtually no contribution to the responses. The direct evaluation
confirmed that the levels of circulating vasopressin increased over 4-fold in response to
stimulation of NTS A1 adenosine receptors.
Since NTS A1 adenosine receptors contribute to the pressor component of the
stress/hypothalamic defense (HDR) response it was interesting if these receptors
contribute to the redistribution of blood from visceral (mesenteric and renal) to somatic
(iliac) vascular beds, which is and integral part of HDR. Therefore, regional vascular
effects of three major vasoactive factors triggered by stimulation of NTS A1 adenosine
receptors (E-adrenergic vasodilation opposed by sympathetic and vasopressinergic
vasoconstriction) were compared; these vasoactive factors differentially affected the
regional vascular beds. The E-adrenergic vasodilation, which dominates in the initial
phase of the response, was significantly greater in the iliac than the mesenteric and
renal vasculatures. Significant sympathetic vasoconstriction was observed in the iliac
but not in the mesenteric and renal vascular beds. In contrast, vasopressin exerted a
marked, sustained vasoconstriction similar in all vascular beds. This pattern of regional
vascular responses suggests that activation of A1 adenosine receptors in the NTS has
minor, if any, effect on the redistribution of blood from the visceral to the somatic
vasculature.
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